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Lactic acid producing bacteria (LAB) and organic acids have been proposed as
effective alternatives to antibiotics, however there is limited literature concerning their
combination. Thus, the objective of this thesis was to investigate the effects of LAB,
encapsulated butyric acid (EBA), and their combination. Under challenged conditions,
the in vitro study demonstrated that both EBA and LAB were capable of reducing
pathogen proliferation over time, with greater efficacy at lower initial concentration.
However, EBA demonstrated a greater effectiveness on pathogen reduction. Under
challenged conditions, the results of the in vivo study indicated that birds fed LAB
performed comparatively to that of birds fed antibiotics concerning BW and FCR from d
0-45 and both diets enhanced gut physiology, pH and immune parameters. Overall, the
results of the thesis indicate the ineffectiveness of combining EBA and LAB, while
providing valuable evidence supporting LAB as an effective alternative to antibiotics.
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CHAPTER I
INTRODUCTION
For over 50 years, the poultry industry has supplemented feed with subtherapeutic
levels of antibiotics (Jones and Ricke, 2003); this has resulted in improved performance,
while reducing illness (Dibner and Richards, 2005). Due to these attributes, antibiotics
have been provided prophylactically in diets as antibiotic growth promoters (AGPs)
(Gaskins et al., 2002). However, due to recent legislation and consumer concerns over the
ability of pathogens to establish antibiotic resistance, the poultry industry has begun to
phase subtherapeutic levels of antibiotics out of poultry diets (Castanon, 2007). With this,
the industry is faced with a challenge of maintaining performance and bird health, while
still providing a safe, affordable product.
To maintain performance and bird health, the industry must seek out alternatives
to antibiotics that are effective, safe, and sustainable. Antibiotics have been shown to
improve performance by improving weight gain, reducing bacteria in the gastrointestinal
tract (GIT), reducing nutrient competition, and reducing immune stimulation (Economou
and Gousia, 2015). To find an effective alternative, the alternative must elicit the same
positive responses as antibiotics when utilized prophylactically. Proposed alternatives
include: exogenous enzymes, competitive exclusion products, prebiotics, probiotics,
herbs, etheric oils, acidic compounds, and bacteriophages (Huyghebaert et al., 2011; Van
Immerseel et al., 2009). Many AGP-free products on the market may utilize more than
1

one AGP alternative in their product to elicit a greater response in birds. However, there
is concern whether the combination of alternatives is detrimental to bird health.
Many manufacturers of alternative products claim their product improves broiler
performance comparative to AGPs; however, there are also inconsistent findings
especially concerning the application of probiotics (Huyghebaert et al., 2011). Many
alternatives fail to elicit all the positive effects that AGPs have been proven to evoke. To
overcome the limiting effects of one alternative, the effects of combining different
antibiotic such as prebiotic and probiotic alternatives is being investigated (Patterson and
Burkholder, 2003). The combined inclusions of prebiotics and probiotics in poultry diets
have been shown to reduce heat stress and improve broiler growth (Sohail et al., 2012;
Mookiah et al., 2014). As synbiosis is reported in the combination of prebiotics and
probiotics, the same may be true for other combinations of antibiotic alternatives (Gaggia
et al., 2010).
Both acidic compounds and lactic acid producing bacteria (LAB), a category of
probiotics, have the potential to improve performance and welfare of poultry. Separately,
both acidic compounds and LAB improve broiler performance through the use of organic
acids, which ameliorate the conditions of the gastrointestinal tract (GIT) by reducing the
colonization of pathogenic bacteria (Huyghebaert et al., 2011). Organic acids, specifically
short chain fatty acids (SCFA), are capable of lowering the surrounding pH of the GIT
directly or the internal pH of enteric bacteria indirectly (Fernández-Rubio et al., 2009).
Through the utilization of organic acids in poultry diets, the pH of the GIT is directly
lowered, ameliorating the conditions of the GIT by promoting nutrient digestibility
through increasing proteolytic enzyme activity, increasing the frequency and volume of
2

enzymatic secretions, promoting growth of beneficial bacteria, and decreasing pathogenic
bacteria (Papatisiros et al., 2013). Although LAB produce organic acids (acetic and lactic
acid) similar to acidic compounds, LAB also produce other metabolites (hydrogen
peroxide and bacteriocins). They are also capable of attaching to the ileal epithelial cells,
which reduces pathogenic colonization (Van Immerseel et al., 2009; Jin et al., 1996).
Further, LAB have the potential to improve the integrity of the GIT, enhance immune
functions, and improve growth performance (Bai et al., 2013; Gaggia et al., 2010; Jin et
al., 1996; Kabir et al., 2004). Organic acids, either in acidic compounds or produced by
LAB, show promise as AGP alternatives, however, little is known on how they may
interact with the other.
Due to the use of organic acids through the administration of acidic compounds
and LAB in poultry diets, there is a possibility the two would benefit off of each other, as
a synergistic effect. However, previous research has linked the administration of acidic
compounds to the reduction of LAB, in vitro (Impey and Mead, 1989; Hume et al., 1997;
Thompson and Hinton, 1997). Due to the necessity of establishing beneficial microflora
in poultry chicks, inhibiting and reducing the colonization of LAB could potentially be
detrimental to the welfare of a newly hatched chick. Intestinal infections have been seen
to occur more severely in germ-free animals than those with an established microflora
(Fuller, 1995). Thus, it is imperative the combination of acidic compounds and LAB be
explored, to distinguish if LAB are destroyed or inhibited from the application of acidic
compounds or if the two work in synergy to promote a healthier bird.
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CHAPTER II
LITERATURE REVIEW
Development of Today’s Poultry Industry
To understand the poultry industry of today, it is important to understand the
history of the domesticated chicken. The modern chicken, Gallus gallus domestica, is
believed to have originated from the red jungle fowl of Asia (Sawyer, 1971). The red
jungle fowl is one of four species from the jungle fowl genus, Gallus. The genus Gallus
encompasses Gallus gallus (red junglefowl), Gallus varius (green junglefowl), Gallus
sonneratii (grey junglefowl), and Gallus lafayetii (ceylon junglefowl) (Al-Nasser et al.,
2007). Gallus gallus, the red jungle fowl, can still be found in regions of India, China,
Java, Malaysia, Indonesia, and Philippine (Al-Nasser et al., 2007).
Origins of the Broiler Chicken
With the development of societies, culture and entertainment began to emerge.
Domestication of the red jungle fowl is said to have occurred primarily due to their use in
cultural and entertainment purposes (Crawford, 1990b). Earliest domestication is
estimated to have occurred around 5400 B. C., however, it is believed the domestication
of chicken occurred between 2500-2100 B. C. in the Harappan culture of the Indus
Valley (Crawford, 1990a and b). Ultimately, the Gallus gallus domesticus is believed to
have origins dating back 3,000 years ago (Crawford, 1990a).
Even before the domestication of the Red Jungle Fowl, poultry had been utilized
for their meat and egg production. Although, it was not an uncommon occurrence to eat
poultry in historic times, poultry was not the primary source of protein. Chickens were
6

used mainly for cockfighting until the mid-1800s when cockfighting was deemed illegal.
After cockfighting was deemed illegal, chickens were sought after for exhibition (Moreng
and Avens, 1985; Crawford, 1990b). As so, eating the species Gallus gallus was
considered a luxury that did not occur but at special events.
The domesticated chicken was brought to America around 1607 by the initial
settlers of Jamestown (Sawyer, 1971). The early breeds of domesticated fowl in America
were so numerous that in 1873 the “American Standard of Excellence” was created to
standardize the poultry breeds in America (Sawyer, 1971). By the 19th century chickens
were an essential part of American agriculture and by the onset of the 20th century
chickens were commonly found on every farm. The chickens of the early 20th century
were mainly possessed for their ability to produce eggs and were sought for their meat
only on rare occasion (Sawyer, 1971). Not until 1923, were chickens raised solely for
their meat.
In 1923, Cecile Steel of Ocean View, Delaware, was mistakenly sent 500 chicks
instead of 50 (Williams, 1998.) Cecile Steele coined the idea to raise the birds as small
broilers and did so by selling her remaining flock of 387 chickens for 62 cents per pound
to local families (Sawyer, 1971). Shortly after, surrounding families sought to also profit
off of raising broilers; and by 1925, Delaware was producing 50,000 broiler chickens
(Sawyer, 1971). Around the same time, range paralysis hit lower Delaware, which
affected leghorns of 12 wks of age or older. This made heavier, younger birds the best
alternative, which increased the growth of the broiler industry (Sawyer, 1971). Soon
after raising chickens became common place in the north, the south also followed suit.
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During the onset of the 20th century, cotton was the main cash crop for the
southern states of the U.S.; however, as times changed and government bureaucrats
became involved, cash incentives were given to farmers who stopped producing cotton
through the Agricultural Adjustment Administration (1933) and later through the Soil
Conservation and Domestic Allotment Act (1936) (Gisolfi, 2006). This drastically
changed the agricultural landscape of the south. Georgia was especially changed by the
diminishing harvest of cotton and many cotton furnishing merchants no longer had a
market in which to sell goods to. This led to the development of furnishing merchants
such as Jesse Jewell, to enter the poultry raising industry (Sawyer, 1976; Gisolfi, 2006).
Jesse Jewell and many other furnishing merchants would sell chicks and feed on credit
until the birds reached a full growout, 12-16 wks (Gisolfi, 2006). Later, this method
would be coined vertical integration (Gisolfi, 2006). The decrease in cotton and shift
towards broiler production in Georgia would increase the states’ poultry production to
500,000 broilers by 1935 (Gisolfi, 2006). Although both the north and the south
established broiler industries as early as 1925, broiler production did not become an
industry with power until the onset of World War II (Williams, 1998). Since then, the
poultry industry has made drastic changes in nutrition, genetics, housing, and veterinary
care (disease control) (Hunton, 1990).
Nutrition
As the poultry industry in the north began to flourish in 1925 and the south in
1935, so did the development of poultry feed and diets. Although Delmarva alone had ten
major brands present during the onset of the broiler industry, the poultry feed market
mainly consisted of local feed mills, who held monopoly over the market (Sawyer, 1971).
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However, larger feed milling companies were more competitive, with greater budgets,
allowing for substantial research and development on broiler diets. In 1925, the first
complete broiler feed was developed by The Beacon Milling Company (Sawyer, 1971).
And as early as 1929, The Beacon Milling Company developed and introduced a
coccidiosis control mash drastically changing the developing field of poultry nutrition
(Sawyer, 1971).
At the conclusion of World War II, the first high-energy broiler diet was
introduced into the broiler industry (Sawyer, 1971). However, this diet was inadequately
proportioned in reference to its energy-protein ratio and thus the concept of “calorieprotein ratio” was introduced in 1955 (Sawyer, 1971). Advancements in feed formulation
were so great that from 1929 to 1969 that the average weight increased from 2.82 pounds
to 3.81 pounds (Sawyer, 1971). To evaluate the drastic changes of broiler nutrition, a
study conducted by Havenstein et al. (2003) investigated the changes in the growth,
livability and feed conversion of 1957 and 2001 broiler fed diets from their respective
era. The results of the study concluded that the average body weight of a Ross 308 fed a
diet from 1957 was only capable of a body weight of 2,126 g compared to the 2001 diet
where the Ross 308 maintained an average body weight of 2,672 g at d 42 (Havenstein et
al., 2003). Feed formulation and the ingredients utilized continue to advance, improving
the production and profitability of broilers.
Genetic Selection
Although nutrition is an important factor that has led to the increase of broiler
growth and size, genetics also plays a huge role in the development and growth of
broilers. Nutrition accounts for 10 to 15 % of the change seen in broiler performance,
9

however genetic selection has brought about 85 to 90 percent of the change (Havenstein
et al., 2003). As demand intensified for a heavier broiler in the early 1900’s, poultry
growers sought to discover the correct breeds for meat growth. Previous to the concept
of raising chickens solely for meat, chickens were predominantly used for egg laying.
Egg laying and broiler production are diametrically opposed, thus a breed designed solely
for meat production would need to become a reality.
By the onset of War World II, there were many breeds of poultry that were
primarily for meat, however there was not a breed with the desired characteristic of a
broad breast, such as the broad breasted turkey possessed (Gordy, 1974). The Chickenof-Tomorrow Contest first appeared in 1946 to address the need for a larger bird and in
1948 the first national contest was held at the University of Delaware (Gordy, 1974). In
1974, the winning bird, a White Cross, reached a weight of 5.7 pounds at approximately
7 weeks and 5 days, while the winning bird of 1949, a New Hampshire-Rock Red Cross,
reached the same weight at 13 weeks and 2 days (Gordy, 1974). One distinct
advancement in genetics following the Chicken-of-Tomorrow Contest is the innovated
cross of a Plymouth Rock to a Cornish Game Hen, producing a superior bird with more
room for breast meat attachment (Skinner, 1974). The Cornish hen originated from
England, where the breed was developed from Asiatic fighting stocks for cockfighting,
whereas, the white Plymouth Rock originated from America from an American parent
breed developed there (Crawford, 1990b). Ultimately, the competitive breeding market
was instilled by the Chicken-of-Tomorrow Contest and led to broilers grown in 2015 to
reach a market weight of 6.24 lbs at 48 days of age with a 1.89 feed conversion ratio
(NCC, 2015). It is apparent that genetic selection greatly contributed to the
10

overwhelming improvement to broiler performance, however, housing and veterinary
care have also played an important role in broiler performance improvements.
Housing
Improvements in broiler performance can be directly connected to the
improvements in the welfare of the birds, whether this includes housing, water, or
veterinary care to treat and prevent diseases and mortalities. Before the onset of the
poultry industry, many farms that had chickens were not concerned with the housing of
poultry and let them free to roost in trees and be susceptible to predators and other
outside dangers (Skinner, 1974).
As the development of the broiler industry began, birds were raised in small sheds
that had access to the outdoors. The sheds may have contained small heaters for the
winter, but besides that aspect, the sheds were not controlled environments (Sawyer,
1971). One of first automated houses were developed in the late 1940s by the DeWitt
brothers of Zeeland, Michigan. The brothers started with the production of an automated
chain feeder (Sawyer, 1971). The automated feeder later became known as the “Big
Dutchman” and led to the DeWitt brothers to invent automated waterers, ventilation
equipment, egg coolers, chick sorters, feed cleaners, and brooders (Sawyer, 1971). The
Big Dutchman organization became one of founding figures in automated housing.
The housing of the 21st century is very different than what was seen in the early
1900s. Broiler housing in the industry currently employs complete climate control with
the ability to manipulate temperature, relative humidity, air composition, air speed, air
movement, and lighting. Because of the advancements in housing technology and
machinery, poultry producers are able to maintain complete control of the climate and
11

environmental conditions in which poultry are housed which is directly linked to the
improvements in growth rate, feed efficiency, and livability (Liang et al., 2013).
Veterinary Care
Improvements in growth rate, feed efficiency, and livability of poultry have also
been a direct effect of the developments in veterinary care. From the beginning of the
industry, medications and drugs were a huge area of concern for the poultry industry as
poultry growers sought to improve efficiency in development of a better bird. Drug
companies thus were very interested in the developing poultry market such as: Hess and
Clark, American Cyanamid, National Remedy Products Company, Whitmoyer, Western
Condensing, Sterwin, Monsanto, Elanco, Vinland, Pfizer, Wyeth, Consolidated Products,
Merck, Commercial Solvents, Abbott, and numerous others (Sawyer, 1971).
Veterinary care in the poultry industry, however, was not a common practice as
the industry began, as servicing poultry was not seen as useful. “Doc” Salsbury
introduced the industry to the idea of providing poultry with veterinary care and
providing growers with the means to identify and treat diseases and afflictions found in
poultry to improve performance (Sawyer, 1971). Dr. Salsbury introduced the industry to
many innovated products and ideas such as an annual poultry school that was created in
1931, an experimental farm to conduct research on proposed products (1935), a product
called Ren-O-Sal that was a leader in the growth promotion movement, feed medications
(1950), and vaccinations distributed through drinking water (Sawyer, 1971). Currently, it
is common practice in the broiler industry to not only employ preventative measures such
as “Doc” Salsbury had recommended, but to utilize service technicians who monitor
broiler farms and advise the growers who manage the facilities. Through the innovative
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measures taken by the broiler industry, the industry has seen a dramatic decrease in
mortality among flocks from 1925 to 2015 as mortality decreased from 18 to 4.8 percent
(NCC, 2015). Of course, nutrition, genetics, and housing have also contributed greatly to
this great improvement in livability among broilers.
Vertical Integration
Although the development of today’s broiler is of utter importance, so is the
development of the industry. The industry of course could not have taken off without
nutrition, genetic selection, housing, water, and veterinary care, but the industry is
primarily responsible for those advancements.
The poultry industry began as a family backyard operation and grew into a
multibillion-dollar industry with approximately thirty-five poultry businesses that control
the operation from start to finish (NCC, 2015). The rapid development of the industry can
be attributed to vertical integration. The term vertical integration was coined by Jesse
Jewell of Gainesville Georgia who in the mid 1930’s was a merchant furnisher who had
the idea to furnish farmers with chicks and feed on credit until the birds were heavy
enough to sell back and settle the debt (Gisolfi, 2006). To begin, Jesse Jewell contacted
feed companies such as Ralston-Purina and Quaker Oats and local banks to receive credit
for the feed and chicks (Gisolfi, 2006). Jewell received the credit easily and extended the
credit to farmers who were given baby chicks and feed on advanced credit. Balances
were settled 12-16 weeks after, the duration it took broilers to experience a complete
growout, when a merchant or other distributor purchased grown broilers (Gisolfi, 2006).
At this time, the mid 1930’s, farmers were not required to sell the broilers back to the
dealers, as farmers were not contractually bound to merchants.
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By 1940, furnishing merchants purchased and owned hatcheries, distribution
facilities, and processing plants (Gisolfi, 2006). These purchases, limited the reliance on
outside sources to maximize profits. As well, merchants began to create contracts in the
mid 1950’s with farmers and implement a “feed-conversion plan” (Gisolfi, 2006). The
contracts defined the expectancies of the farmers to supply the broiler houses, equipment,
labor, heat, and litter and to sell the grown broilers solely to the merchant they were in
contract with. As well, the “feed-conversion plan” was a method to determine the profit
the farmers would receive based on the pounds of chicken the merchants received from
the pounds of feed the farmers used to raise the birds (Gisolfi, 2006). The contracts and
the “feed-conversion plan” may have taken away from the independence of the farmer,
however, it did establish uniform practices and contractual farming through vertically
integrated businesses.
The business style of merchants like Jesse Jewell, revolutionized the industry of
today where vertical integration is still heavily relied upon. It is also apparent the
advancements made in nutrition, genetics, housing, and veterinary care in the broiler
industry continue to allow the broiler industry to grow and see improvements in
efficiency and growth in broiler performance. As such, the industry is an integral part of
the United States economy and the U.S. possesses the largest broiler chicken industry in
the world and Americans consume more chicken than anyone else in the world per capita
(NCC, 2015). In fact, the retail value of the broiler industry in 2010 was valued at $45
billion (USDA, 2012). As the broiler industry is an important aspect of the American
economy, diet, and lifestyle it is evident that the industry must continue to grow to meet
consumer demand and developing challenges in the industry.
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Industry Challenges
With the drastic improvements in the poultry industry, challenges have also risen.
Such challenges to arise include the increase of incidences of foodborne illness and
poultry diseases originating from pathogenic bacteria. Foodborne illness originating from
a poultry source can be traced primarily to Salmonella, Escherichia coli, and
Campylobacter. In 2013, foodborne illnesses were identified by FoodNet to be
responsible for 19,056 cases of infection, 4,200 hospitalizations, and 80 deaths (CDC,
2014a). Poultry is estimated to be the source of 10% of all foodborne illnesses, 12% of all
hospitalizations, and 19% of foodborne related deaths from 1998- 2008 (Painter et al.,
2013). As well, poultry diseases attribute 10 to 20% of production cost in developed
countries (FOA, 2016). Although these estimates include other foodborne illness and
diseases, it does not diminish the detrimental effects of pathogenic bacteria on consumers
and poultry.
Foodborne Illness
Salmonella spp. are gram-negative, aerobic bacteria that flourish at an optimal
temperature of 37°C and can cause typhoidal fever, enteric fevers, gastoenteritis, and
septicemia (Holt et al., 2000). Each year in the U.S., the CDC estimates there are 1.2
million cases of Salmonellosis (non-typhoidal), resulting in 450 deaths (Scallan et al.,
2011). In 2012, 106 of the 831 foodborne outbreaks were directly related to Salmonella
and from the reported outbreaks that year 64% of the hospitalizations were confirmed to
be caused by Salmonella (CDC, 2014c). In 2013, Salmonella accounted for the most
incidences of foodborne illness in the U.S., with Enteritidis, Typhimurium, and Newport
as the top serotypes (CDC, 2014a). Salmonella (nontyphoidal) is estimated to be the top
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cause of pathogen related hospitalizations (19,336), and death (378) and the second
leading cause of reported foodborne illnesses (1,027,561) (CDC, 2011). Consequently,
incidences of Salmonella, especially Enteritidis can be directly linked to poultry and eggs
(CDC, 2014a).
Campylobacter spp., are gram-negative, microaerophilic bacteria, and are
responsible agents for causing Campylobacteriosis, an infectious GIT disease (Holt et al,
2000). Cambylobacteriosis is caused by pathogenic spp. such as Campylobacter jejuni,
that prefer an environment around 37°C to 42°C, the internal temperature of poultry (4142°C) (CDC, 2014b; Holt et al., 2000). Campylobacter can be found in the oral cavity,
GIT, and reproductive organs of humans and animals (Holt et al., 2000).
Campylobacteriosis has been identified as one of the leading causes of foodborne illness
in the U.S. and is estimated to affect more than 1.3 million persons every year and result
in 76 deaths per year (CDC, 2006; CDC, 2014b). As well, a 14% increase has been
reported in Campylobacter illnesses from 2006-2008 to 2012 (CDC, 2013). As poultry
are estimated to be responsible for roughly half of Campylobacter-associated illnesses, it
is imperative to mitigate and control this pathogen (Harris et al., 1986).
Escherichia coli is a facultative-anaerobic, gram negative bacteria that colonizes
the lower part of the GIT of animals (Holt et al., 2000). Certain E. coli strains are capable
of producing enterotoxins and colonization, thus causing diarrheal illness in the host
(Holt et al., 2000). Pathogenic Escherichia coli (0157) is one of the top five pathogens
resulting in hospitalization and is estimated to be the cause of 2,138 cases of
hospitalization (CDC, 2011). Of the reported foodborne illness cases, hospitalizations,
and deaths between 1998- 2008, 18 , 16 , and 30% of the cases, respectively, were related
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directly to bacteria (Painter et al., 2013). It is apparent that the industry, even with its
drastic developments and improvements, still has a challenge with pathogenic bacteria on
poultry products.
Poultry Disease
Not only have pathogenic related foodborne illnesses become an issue, but an
increase in concern for disease outbreaks among poultry caused by pathogenic bacteria
has occurred. Such diseases include Necrotic Enteritis, Fowl Typhoid, Paratyphoid, and
Colibacillosis, which are directly related to pathogenic bacteria in the poultry industry
(Merck Manual, 2013). Pathogens such as Salmonella, Clostridium perfringens, and
Escherichia coli are main concerns for the industry and are commonly present in the
gastrointestinal tract of poultry. The presence of pathogens is a great concern, as it can
cost the industry not only time and money, but the welfare of the birds.
Necrotic Enteritis is an infection of the GIT caused by Clostridium perfringens,
Type A or C (Porter, 1998). Clostridium spp. are anaerobic, gram-positive bacilli that are
spore forming and distributed in the soil and fresh water (Porter, 1998). Pathogenic
Clostridia, such as Clostridium perfringens, can naturally be found in the GIT of animals
(Shapiro and Sarles, 1949). Necrotic Enteritis occurs primarily in broilers of 2-6 wks of
age, producing enteric lesions in the small intestine (jejunum and ileum) (Porter, 1998;
Cooper and Songer, 2010). Annually, Necrotic Enteritis outbreaks are estimated to cost
over $2 billion globally (Van der Sluis, 2000). Further, Necrotic Enteritis causes the
intestines to become distended and filled with dark, brown fluid (Porter, 1998). Necrotic
Enteritis typically occurs simultaneously or as a secondary infection from a coccidia
infection (Shane et al., 1985). Coccidiosis is an enteric disease caused by Eimeria
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species. E. maxima, E. acervulina, and E. necatrix are the most suitable species to induce
Necrotic Enteritis in broilers (Williams, 2005).
Fowl Typhoid, Paratyphoid, and Pullorum are associated with Salmonellagenerated enteric lesions (Porter, 1998). As stated previously, Salmonella is a gramnegative, aerobic bacterium that commonly resides in poultry. The GIT of poultry are
common sites of colonization and thus, the fecal-oral route is a common mode of
transmission (Porter, 1998). The aforementioned lesions predominately occur in the
cecum of infected birds (Porter, 1998). Salmonella pullorum and Salmonella gallinarum
are responsible for Pullorum and fowl typhoid respectively (Porter, 1998). Both Pullorum
and fowl typhoid affect young birds up to three weeks; however, fowl typhoid persists
into adulthood. Because fowl typhoid can persist into adulthood, it can be transmitted
from the hen to the egg through vertical transmission (Porter, 1998). White, raised,
caseous lesions or gray, necrotic foci occur in the lungs, heart, spleen, liver, gizzard and
kidney of poultry infected with both Pullorum and fowl typhoid (Porter, 1998).
Paratyphoid encompasses most other serotypes, include S. typhimurium, S. Enteritidis, S.
Montevideo, and S. Heidelberg (Porter, 1998). Because these serotypes are commonly
associated with foodborne illnesses, they are of high concern to the industry. Paratyphoid
infections affect young birds with high mortality, however, older birds are nonsymptomatic shedders of the disease (Porter, 1998). In the United States, poultry-related
Salmonella costs the economy an estimated $966 million in direct and indirect costs each
year (Callaway, et al., 2008).
Colibacillosis in chickens is an infectious disease cause by Escherichia coli, a
common pathogen found in the GIT of poultry (Porter, 1998; Gross, 1994). E. coli can
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be either a primary or secondary pathogen; however, due to its common presence in
healthy birds, it is presumed to be more of an “opportunistic” secondary pathogen
(Porter, 1998). Yolk sac infection, respiratory disease complex (airsacculitis,
perihepatitis, pericarditis), acute septicemia, salpingitis, peritonitis, synovitis,
osteomyelitis, cellulitis, and enteric coligranuloma are all common syndromes due to the
disease (Porter, 1998).
It is well known that the gastrointestinal tracts (GIT) of poultry are the main
source of contamination of poultry carcasses within processing facilities (Rigby et al.,
1980). However, the feathers are also a major concern for contamination as Salmonella
spp. contamination normally occurs from external contaminants; whereas,
Campylobacter spp. occur internally (Bailey and Cox, 1991; Jones et al., 1991). Also,
recent Salmonella outbreaks have been linked to animal contact, indirect and direct
(Steinmuller et al., 2006). Hale and colleagues (2012) estimates animal exposure to be
responsible for 11% of Salmonella infections. As the colonization of the GIT occurs
before processing, pathogenic bacteria must be controlled on the farm to mitigate the
bacterial load sent to processing as well as to farmers who handle the birds.
Antibiotic Use in the Industry
After the rapid expansion of the poultry industry in the 1940s, there was a need
for basic feed components. Due to the growth of poultry industry, there was a shortage of
fishmeal and other animal protein sources (Jones and Ricke, 2003). With the necessity for
more animal protein sources, the industry sought to determine what the Animal Protein
Factor (APF), the factor in animal protein sources that promoted increased poultry
performance, consisted of and to find a suitable alternative (Jones and Ricke, 2003). APF
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was later discovered to be Vitamin B12 in 1948 (Jones and Ricke, 2003). Ultimately, the
search to find an effective alternative to APF helped fuel the discovery of antibiotic
growth promoters (AGPs).
Alexander Fleming, an English scientist, discovered penicillin in 1928 when he
was testing the ability of mold to reduce Staphylococci on agar plates (Jones and Ricke,
2003). However, it took until the early 1940s for scientists, Ernst Chain and Howard
Florey, to isolate a sufficient quantity of penicillin to be tested and validated as an
effective treatment for illnesses (Jones and Ricke, 2003). Shortly after the discovery of
antibiotics, a growth promoting component of fungal mycelia, an antibiotic, was observed
outperforming APF, vitamin B12 (Jones and Ricke, 2003). Moore et al. (1946) included
antibiotics in chicken feed and was the first scientist to show an increase in weight gain
due to the inclusion of antibiotics. Later, the use of antibiotics in feed would be coined to
the term AGPs and be utilized for prophylactic purposes that prevent or reduce the risk
for infection, as well as promote growth in broilers.
AGPs in the poultry industry are administered in the diet when there is no clinical
sign of infection, however the risk still exists. Prophylactic use of AGPs have resulted in
improved weight gain, reduced bacterial presence in the gastrointestinal tract, reduction
in nutrient competition, and reduced immune stimulation (Economou and Gousia, 2015).
After the introduction of AGPs to the industry, there were concerns for the residues in
meat and fungal overgrowth in animals. As time progressed, the concerns have evolved
due to consumer perception and scientific reports (Jones and Ricke, 2003).
The poultry industry has begun to turn away from the use of antibiotics due to
growing public concern over antibiotic resistant pathogens. As early as the late 1960s,
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the Swann Committee in the European Union researched the possibility of bacterial
resistance due to the use of antibiotics in livestock diets (Doeschate and Raine, 2006). It
was found in the years between 1963 and 1965 that the resistance to antibiotics could be
transferable to other bacteria, as was seen in the epidemic of resistant Salmonella
typhimurium (Doeschate and Raine, 2006). The epidemic of S. typhimurium led the UK
government to appoint the Swann Committee to monitor and identify possible resistance
of pathogenic bacteria to antibiotics from animal origins (Doeschate and Raine, 2006).
The Swann Committee later recommended in 1969 that the antibiotics used as growth
promoters in feed diets be those that ‘have little or no application as therapeutic agents in
man or animals and will not impair the efficacy of a prescribed therapeutic drug or drugs
through the development of resistant strains of organisms’ (Doeschate and Raine, 2006).
The Swann Committee in that same statement deemed the use of chlortetracycline,
oxytetracycline, penicillin, tylosin, and the sulphonamides as unsuitable for growth
promotion (Doeschate and Raine, 2006). The statement was later adopted by the UK in
1998. As the continued concerns grew in the UK and across the world, the poultry
industry would experience extreme pressure to terminate the use of antibiotic growth
promoters in the diet of poultry and other livestock.
The first country in Europe to officially ban the use of antibiotic growth
promoters was Sweden in 1985 (Doeschate and Raine, 2006). Sweden, after joining the
European Union in 1995, employed heavy pressure on the rest of the European Union to
ban the use of antibiotics as growth promoters (Doeschate and Raine, 2006). In 1996, the
United States implemented the National Antimicrobial Resistance Monitoring System
(NARMS) which monitored the antimicrobial resistance in bacteria (Jones and Ricke,
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2003). Around that same time (1997 and 1998), the World Health Organization and
Economic and Social Community of the European Union deemed the use of
antimicrobials in food animals as a public health concern, citing risks to long term use of
antibiotics, such as resistance to antibiotics (Castanon, 2007).
However, since the poultry industry does not employ antibiotics that are absorbed
by the digestive tract, the concern for residue of antibiotics in meat and meat products is
not a direct concern (Castanon, 2007). In 2006, Europe drastically reduced the amount of
antibiotics utilized in animal feeds, which resulted in a substantial increase of therapeutic
antibiotics for food animals (Castanon, 2007). The European Union finalized the ban on
Antibiotic Growth Promoters (AGPs) with the creation of Regulation 1831/2003 which
eliminated the use of all AGPs as of January 1, 2006 (Castanon, 2007). Though the
overall use of antibiotics has decreased by 55% from 1986 to 1999 and there has been a
low prevalence of antimicrobial resistance, there is still concern for the increase in use of
therapeutic antibiotics due to the increase in infections (Castanon, 2007).
Current concerns over antibiotic resistance have been backed by the prevalence of
antibiotic resistance stemming from livestock origin. Poultry have been linked to the
resistance of Campylobacter and Salmonella to multiple antibiotics. For example, a few
years after the introduction of fluoroquinolones in the Netherlands, there was an increase
on fluoroquinolone-resistant Campylobacter of poultry origin (Economou and Gousia,
2015). The European Union also experiences gentamicin resistance in Campylobacter
from broiler meat origins that ranges from 0% to 6.3% (Economou and Gousia, 2015).
The United States, has seen Campylobacter Coli resistance to gentamicin increase from
1% in 2007 to 18% in 2011 from chicken meat isolates and an increase from 1% to 6%
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between 2007 and 2011 from chicken isolates at slaughter (Economou and Gousia, 2015).
In addition, Salmonella spp. have been noted to have developed a multi-drug resistance to
antibiotics such as tetracyclines, sulfonamides, streptomycin, kanamycin,
chloramphenicol, and some β-lactam antibiotics (Economou and Gousia, 2015).
However, there has been a relatively stable reporting of resistance among these
antibiotics since 1996 (Economou and Gousia, 2015). The resistance to other antibiotics
has increased relatively, as seen in amoxicillin/clavulanic acid and ceftiofur, in which has
seen an increase from less than 2% to 15% from 1998 to 2005, respectively (Economou
and Gousia, 2015).
Currently, the United States poultry industry has begun phasing out antibiotic
growth promoters partly due to the increase in consumer concern over the usage of AGPs
and the increase in AGP free exportation requirements. However, many growers have
discovered an increase in “dysbacteriosis,” a condition in which the small intestines’
experiences bacterial overgrowth (Huyghebaert et al., 2010). The solution is to find an
alternative with similar effects as AGPs such as: (1) reducing the number of incidences
and the amplitude of subclinical infections; (2) reducing the use of nutrients by bacteria;
(3) improving absorption through the thinning of the intestinal wall; and (4) by reducing
the amount of ‘growth-depressing metabolites’ produced by Gram-positive bacteria.
(Huyghebaert et al., 2010).
Alternatives to Antibiotics
Many alternatives have been proposed to replace AGPs in the poultry industry
such as: exogenous enzymes, competitive exclusion products, prebiotics, probiotics,
herbs, etheric oils, acidic compounds, and bacteriophages (Huyghebaert et al., 2010; Van
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Immerseel et al., 2009). The most common alternatives applied in current broiler diets are
prebiotics, probiotics, and organic acids. All are utilized with the ultimate goal of
ameliorating the condition of the gastrointestinal tract of poultry by mitigating the
presence of enteric bacteria present in the GIT and improving the production of the bird
(Van Immerseel et al., 2009). It is of interest for this thesis to determine how each
alternative accomplishes its goal of improving the gut health of the bird. Both organic
acids and probiotics work through similar methods as many probiotics improve the
physiology and anatomical structure of the intestinal cell wall, enhancement of
immunological functions in the gastrointestinal tract (GIT), and the enhanced resistance
to enteropathogenic bacteria by producing short chain fatty acids, hydrogen peroxide, and
intermediary metabolites with antimicrobial activity (Huyghebaert et al., 2010). And
organic acids primarily consist of SCFAs. Thus, organic acid and probiotic supplements
are similar because probiotics are capable of producing organic acids which act similar to
the actual organic acid supplements.
Organic Acids
Organic acids are organic compounds that retain acidic properties. Most organic
acids consist of carboxylic acids (-COOH). Organic acids are primarily composed of
short chain fatty acids (SCFAs) such as fumaric, propionic, acetic, lactic, butyric, and
others. Organic acids were originally added to feed for sanitization purposes such as to
reduce fungal contamination in feed and as a preventative against salmonellosis in
poultry (Ricke, 2003; Thompson and Hinton, 1997). However, in the past 30 years,
formic and propionic acid have been examined for bactericidal activity, in vivo, of
poultry (Ricke, 2003). Organic acids utilized in feed are not only capable of
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decontaminating feed, but have the potential to reduce enteric bacteria internally in
poultry.
Weak organic acids (C1-C7, SCFA) with a pKa between 3 and 5 are used
specifically for their antimicrobial activity (Papatisiros et al., 2013). There are two major
types of organic acids. The first group (lactic, fumaric, citric) are capable of lowering the
pH of the stomach, thus reducing the bacteria present indirectly. The second group
(butyric, formic, acetic, propionic, and sorbic) lower the pH in the gastrointestinal tract
by directly acting upon the cell wall of Gram-negative bacteria (Diener et al., 1993;
Papatisiros et al., 2013). Organic acids ameliorate the conditions of the GIT through the
reduction of GIT pH, promoting proteolytic enzyme activity and nutrient digestibility,
intensifying pancreatic secretions, encouraging digestive enzyme activity, creating
stability of the microbial population and stimulating the growth of beneficial bacteria,
and by being bacteriostatic and bactericidal to pathogenic bacteria (Papatisiros et al.,
2013). With the need to find a suitable alternative to AGPs, many different organic acids
have been utilized in poultry diets for the potential to mitigate pathogen prevalence in the
GIT of poultry.
As previously mentioned, organic acids can benefit poultry internally is through
their ability to lower the pH of the gastrointestinal tract. It has been found that organic
acids such as fumaric, propionic, lactic, and sorbic acid have the ability to reduce the
colonization of pathogenic bacteria and the production of toxic metabolites through
acidification of the diet (Kirchgessner and Roth, 1988). Although the crop and gizzard
are the locations in which propionic and formic acid are confined to, the crop is the
primary location for Salmonella to cause infection (Thompson and Hinton, 1997). It has
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also been demonstrated that most Salmonella spp. are killed when the pH value is the
equivalent to that of the crop and proventriculus, in vitro (Cox et al., 1972). As well,
vertical transmission of Salmonella can be reduced with organic acids as well as initial
colonization of chick though organic acids being included in the diet (Ruhnke et al.,
2014). Though organic acids can benefit poultry by directly lowering the pH of the GIT,
organic acids can also benefit poultry though directly harming bacteria.
Although the most noted benefit of organic acids is its ability to lower the pH of
the GIT, organic acids can also prevent pathogen livability on the cellular level. Organic
acids possess the ability to target the cell wall, cytoplasmic membrane, and specific
metabolic functions in the cytoplasm associated with replication, protein synthesis, and
function (Ricke, 2003). Volatile short-chain fatty acids (VSCFA), consisting of weak
organic acids that are bacteriostatic without affecting intestinal microflora, are not
regarded as acidifiers as their mode of action is to directly diffuse across the cell
membrane of bacteria in the undissociated form without lowering the bowel pH
(Fernández-Rubio et al., 2009). VSCFA once diffused across the bacterial cytoplasm,
lowers the internal pH of the bacteria (Fernández-Rubio et al., 2009).
The effectiveness of organic acids relies heavily on several factors such as: type
and acidity of the SCFA, inclusion rate of acids, diet composition and buffering within
the diet, level of “intraluminal production of acids” by lactic acid producing bacteria
(LAB) in GIT, feed palpability, receptor on the epithelial villi for bacterial colonization,
vaccinate immunity, welfare, and age (Papatisiros et al., 2013).
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Lactic Acid Producing Bacteria
Lilley and Stillwell originally conceived the term probiotics as ‘a substance
produced by one microorganism which stimulated the growth of another’ in 1965, well
after the discovery of antibiotics (Fuller, 1995). Although the term was not coined until
after the discovery of antibiotics, probiotics had been around since the early 20th century
(Fuller, 1995). As time went on and more knowledge was obtained on the subject of
probiotics, the definition started to change to better define their usefulness and
application. In 1989, the definition was modified to a “live microbial feed supplement
which beneficially affects the host animal by improving its intestinal microbial balance”
by Roy Fuller (Fuller, 1995). Three years later in 1992, Havenaar and Huis in’t Veld
extended the definition to “a mono or mixed culture of live microorganisms which,
applied to animal or man, affect beneficially the host by improving the properties of the
indigenous microflora” (Fuller,1995). The definition of probiotics has now been
established by Fuller as “a preparation consisting of live microorganisms or microbial
stimulants which affects the indigenous microflora of the recipient animal, plant or food
in a beneficial way” (Fuller, 1995).
Microorganisms that are considered as probiotics include: lactic acid producing
bacteria, avirulent mutants of E. coli, Clostridium difficile, and S. typhimurium, yeasts,
fungi, viruses and bacteriophages (Fuller, 1995). Probiotics serve to protect the GIT
microflora through bacterial antagonism, bacterial interference, barrier effect,
competitive exclusion and colonization resistance (Fuller, 1995).
There are two categories of probiotics, colonizing and non-colonizing species.
Those that are colonizing species are Lactobacillus and Enterococcus spp., while Bacillus
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spp. and Saccharomyces cerevisiae are free flowing, and do not colonize (Huyghebaert et
al., 2010). As stated earlier, probiotic benefit includes: onset of changes of the
physiology and anatomical structure of the intestinal cell wall; enhancement of
immunological functions in the GIT; and the enhanced resistance to enteropathogenic
bacteria (Huyghebaert et al., 2010). These actions are completed typically coupled with
the production of short chain fatty acids, hydrogen peroxide, and intermediary
metabolites with antimicrobial activity (Huyghebaert et al., 2010). The most well-known
group of probiotics are lactic acid producing bacteria, such as Lactobacillus. Lactic acid
producing bacteria (LAB) are able to produce lactic acid in vitro and the lactic acid
produced is utilized for the production of butyric acid by Clostridial clusters, which
introduces the concept of cross-feeding (Huyghebaert et al., 2010).
The most common probiotics are from the genera Lactobacillus, Enterococcus,
Pediococcus, and Bacillus; however, more research has been conducted on Lactobacillus
species (Jin et al., 1996; Tsai et al., 2005; Van Coillie et al. 2007). Lactobacillus spp.
have been found to reduce pathogenic attachment to the ileal epithelial cells through
exclusion and competition (Jin et al. 1996). Lactobacillus also works by producing lactic
acid (Tsai et al., 2005). Lactic acid, an organic acid, is capable of lowering the pH of the
GIT, thus creating a less desirable environment for pathogenic bacteria. Lactobacillus
acidophilus is found to be the most sufficient candidate as a dietary appurtenance
(Havenaar and Huiint Veld, 1992). L. acidophilus has the potential to decrease the
external pH to lower values than other lactic acid producing bacteria, and can reach a
medium pH of 3.5 (Kashket, 1987). Thus, Lactobacillus spp. are excellent candidates as
AGP alternatives.
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Mechanisms of Organic Acids Versus Lactic Acid Producing Bacteria
Research has demonstrated that both organic acids and LAB have the capability to
improve broiler performance and reduce pathogenic bacteria (Gunal et al. 2006;
Vlademirova and Sourdjiyska, 1996; Jin et al., 1998; Vogt et al., 1981; Runho et al.,
1997). Since the modes of action for both organic acid supplements and LAB both
involve the lowering of the pH of the GIT, many of their benefits are the same. However,
LAB and organic acids are still very different in their effectiveness, mechanisms, and
interaction with one another.
Though lactic acid producing bacteria do not directly destroy enteric bacteria,
LAB are able to inhibit colonization and development of pathogenic bacteria. Further,
LAB byproducts such as SCFAs, hydrogen peroxides, and intermediary metabolites are
able to reduce pathogens present in the GIT. In fact, research has demonstrated when S.
Enteritidis at 106 cfu and L. salvarius at 108 cfu were gavaged orally and simultaneously
into the proventriculus of d1 broiler chicks’, at 21 d all birds were negative for
Salmonella (Pascual et al., 1999). It has been noted that SCFAs when interacting with
gram-negative bacteria are not only bacteriostatic, but also bactericidal (Thompson and
Hinton, 1997). Further, some organic acids, primarily SCFAs, are produced in millimolar
concentrations in the GIT of food animals where anaerobic bacteria are more prevalent.
Organic acids, being SCFA, also have the ability to lower the pH of the GIT track and
improve broiler performance similar to LAB. Thus, previous research has seen both
methods to be beneficial in the reduction of pathogenic bacteria (Gunal et al. 2006;
Vlademirova and Sourdjiyska, 1996; Jin et al., 1998; Vogt et al., 1981; Runho et al.,
1997).
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Some concerns for the usage of organic acids include their inability to affect the
lower part of the GIT, bacteria’s ability to create a resistance against organic acids, and
their hindering effect on LAB. Thompson and Hinton noted as SCFAs move along the
digestive tract, their concentration decreases due to digestion and metabolism (Thompson
and Hinton, 1997). It has also been seen by Hume et al. (1993) that most of the propionic
acid that was in the treated feed did not get past the crop, proventriculus, and gizzard and
thus never reached the small intestines (Ricke,2003). Most organic acids will dissociate
before reaching the lower GIT and thus having little to no effect on the GIT (Hume et al.,
1993). Though it was stated earlier that a primary site of infection of Salmonella is the
crop, it is important for organic acids to enter the lower GIT, as it is unlikely for organic
acids to prevent a large infectious dose of Salmonella from getting past the crop
(Thompson and Hinton, 1997).
Another challenge of using of organic acids as an alternative to AGP is the
resistance bacteria can develop to stressful environments. E. coli is capable of building a
tolerance to environments that induce stress (organic acids) (Ricke, 2003). Also, it was
observed by Conner and Kotrola (1995) that E. coli has the ability to live in acidic
condition (pH≥4.0) below 4.0˚C and for up to 56 d, however the temperature and type of
acidifier affect their survival.
Not only can bacteria build a resistance to organic acids, but pathogenic bacteria
can also lower their internal pH to protect themselves from the acidic properties of
organic acids, thus rendering them ineffective in being bactericidal against pathogenic
bacteria (Ricke, 2003). Further, fermentative bacteria have the ability to lower their
intracellular pH in an event that the extracellular pH becomes highly acidic. If the
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intracellular pH is lowered, the bacterium has a much smaller pH gradient across the cell
membrane and will be protected from anion accumulation (Ruhnke et al., 2014).
The biggest challenge to organic acid use is their potential detrimental effect on
LAB. In previous research the use of organic acids in the diet has reduced the amount of
lactic acid and LAB present in the GIT. As early as 1989, Impey and Mead (1989) found
that adding 1.0 % formic acid into a food slurry containing Salmonella and Lactobacilli,
everything was killed (pH<4.0; 37°C). It was also seen by Hume et al. (1993) that
organic acids reduced LAB. The most interesting research came to the conclusion that
LAB were reduced by the inclusion of organic acids (Thompson and Hinton, 1997). In
one of the studies conducted by Thompson and Hinton (1997), 68% formic acid and 20%
propionic acid, organic acid product, was added to a poultry diet and resulted in an
increase of propionic and formic acid, as well a decrease in lactic acid in the crop. This
interaction suggests that propionic and formic acid inhibit LAB. Thus, SCFA may be
counterproductive to the overall development of microflora in the GIT of broiler
chickens.
Poultry are born without an established microflora in their GIT and are removed
from maternal care to be incubated in a controlled environment. Thus, poultry have
difficulty in establishing beneficial microflora (Fuller, 1995). Research has shown that
intestinal infections affect germ free animals more than those with an established
microflora (Gordon et al., 1966; Koopman et al., 1984). Probiotics have been especially
important in improving the microflora of poultry, as well as protecting poultry from
intestinal infection and are recognized as an alternative to AGPs. If the use of organic
acids in poultry reduces the concentration of LAB present in the GIT, it could mean a
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greater chance of Salmonella concentrating the GIT. This especially could occur as
organic acids are limited to the crop and may not be able to handle a high inclusion of
Salmonella (Thompson and Hinton, 1997). Probiotics (LAB) serve to protect the GIT
microflora through bacterial antagonism, bacterial interference, barrier effect,
competitive exclusion and colonization resistance (Fuller, 1995). LAB are not only
beneficial in protecting the bird from pathogens, but also provides the bird with physical
enhancements to the GIT. These enhancements include strengthen gut wall integrity,
enhance anti-inflammatory response, and correct dysbacteriosis (Van Immerseel et al.,
2009). With all of the benefits that LAB provide to poultry, it is important to ensure their
survival and utilization in poultry.
As both organic acids and LAB are potential alternatives to AGPs, it is imperative
to understand the effect each method has on bird performance and welfare, as well as the
interactions they have on one another within the bird.
Conclusion
As the poultry industry is faced with increased demand for no antibiotics ever
(NAE), an acceptable alternative to antibiotics needs to be identified. It is also important
that this alternative is easily integrated into nutrition, genetics, housing, and veterinarian
care for future application. Thus, it is imperative for research to be conducted to
determine the most effective method, organic acids or LAB, in reducing pathogenic
bacteria in the gut, improving broiler performance, and improving gut morphology. It is
also important to investigate the effect of combining organic acids and LAB in poultry
diets.
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CHAPTER III
EFFECTS OF AN ENCAPSULATED BUTYRIC ACID AND LACTIC ACID
BACTERIA ON THE DIMINUTION OF AN ANTIBIOTIC RESISTANT
STRAIN OF SALMONELLA HEIDELBERG, IN VITRO
Abstract
Lactic acid producing bacteria and organic acids are being investigated as
alternatives to antibiotic feed additives to control pathogen prevalence in the
gastrointestinal tract. In this study, the objective was to determine the effect of these two
feed additive products on the growth of an antibiotic resistant strain of Salmonella
Heidelberg (S). The two products consisted of a probiotic supplement, containing L.
acidophilus, L. rhamnosus, B. thermophilum, and E. faecium (P) and an organic acid
product, consisting of encapsulated butyric acid (B). Thus, the treatments consisted of the
2 products (P, B) and the combination of S and products (S+P, S+B). A 12 h stock of S
was diluted 10- fold to provide 107, 106, and 105 cfu/mL, the control. 1 g of product was
weighed and reconstituted in 9 mL of broth. For combinations, 1 mL of S stock culture
(107, 106, and 105) was added to broth containing 1 g of product. After treatments were
prepared, 100 μl was serially diluted at 0, 2, 4, 6, and 8 h of incubation and spread plated
onto Tryptic Soy Agar (TSA) containing nalidixic acid and incubated under aerobic
conditions at 37˚C for 24 h. Log transformed counts were analyzed using a randomized
complete block design with split plot over incubation time. Means were separated using
Fisher’s protected LSD when P ≤ 0.05. A S concentration by time by treatment
interaction was present for S growth (P<0.0001). At all times and S concentrations, S
growth was significantly less in both treatments compared to the control. S growth in
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both the control and S+P was increased over time, however S+B did not show the same
trend in growth. S growth in S+B plateaued after 4 h and maintained that level of growth
throughout the remainder of the study. Also, products were more effective as S
concentrations decreased, with products being most effective at 105 cfu/mL of S (8h at
105 cfu/mL Salmonella concentration: Control = 7.59, S+P = 6.29, and S+B = 4.03 logs
cfu/mL (P<0.0001)). In conclusion, both products are capable of reducing an antibiotic
resistant strain of S, with butyric acid having the greatest reduction capabilities.
However, further research needs to be conducted to evaluate the effect of these products
in poultry diets.
Introduction
Over 9 million Americans suffer from foodborne illnesses a year from major
pathogens, with over 40% of those illnesses being attributed to land animals (Painter,
2013). From 1998 – 2008, poultry related illnesses were identified as the third leading
cause of hospitalizations (12%), the leading cause of death (19%), and the second leading
cause of bacterial illness (18%) (Painter et al., 2013). Poultry related foodborne illness
are commonly associated with the presence of Salmonella, Escherichia coli, and
Campylobacter.
Salmonella spp. gram-negative, aerobic bacteria, flourish at an optimal
temperature of 37°C and can cause typhoidal fever, enteric fevers, gastoenteritis, and
septicemia (Holt et al., 2000). Each year in the U.S., the CDC estimates there are 1.2
million cases of Salmonella (non-typhoidal), resulting in 450 deaths (Scallan et al., 2011).
In 2013, Salmonella accounted for the most incidences of foodborne illness in the U.S.,
with Enteritidis, Typhimurium, and Newport as the top serotypes (CDC, 2014a).
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However, the serotypes most commonly associated with poultry and poultry product
related outbreaks are S. Enteritidis, S. Typhimurium, and S. Heidelberg causing 32, 13,
and 8 % of all Salmonella outbreaks, respectively (CDC, 2013). Salmonella
(nontyphoidal) is estimated to be the top cause of pathogen related hospitalizations
(19,336), and death (378) and the second leading cause of reported foodborne illnesses
(1,027,561) (CDC, 2011). In 2012, 106 of the 831 foodborne outbreaks were directly
related to Salmonella and from the reported outbreaks that year, 64% of the
hospitalizations were confirmed to be caused by Salmonella (CDC, 2014c).
Consequently, incidences of Salmonella, especially Enteritidis can be directly
linked to poultry and eggs (CDC, 2014a). Not only does Salmonella pose as a threat to
humans, but also to poultry. Presence of Salmonella spp. is a welfare concern, as
Salmonella pullorum and Salmonella gallinarum are the causative agents of Pullorum
Disease and Fowl Typhoid, respectively (Merck Manuals, 2013). Further, mortalities due
to diseases attribute 10 to 20% of production cost in developed countries (FOA, 2016).
Although the latter estimates include other foodborne illness and diseases, it does not
diminish the detrimental effects of pathogenic bacteria on consumers and poultry.
Antibiotics have commonly been used prophylactically in the poultry industry to
not only reduce pathogenic bacteria in the gastrointestinal tract (GIT), but improve
weight gain, reduce nutrient competition, and reduce immune stimulation (Economou and
Gousia, 2015). However, due to recent legislation and consumer pressure, concerning the
development of antibiotic resistance, antibiotics are being withdrawn from some
commercial poultry diets (Castanon, 2007). With the removal of antibiotics, poultry are
more susceptible to disease, dysbacteriosis, and poor performance (Huyghebaert et al.,
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2010). Thus, integrators are not only left with the challenge of maintaining broiler
performance, but also controlling the bacteria in the GIT. An imbalance in the residential
GIT microflora of poultry can increase both incidences of foodborne illnesses and poultry
diseases, due to an increase in pathogenic bacteria presence in the GIT.
With the increase of consumer concern over the development of antibiotic
resistance, alternatives need to be explored in order to reduce and prevent the
proliferation of pathogenic bacteria, such as Salmonella (Economou and Gousia, 2015).
Proposed alternatives to antibiotics in poultry diets include: exogenous enzymes,
competitive exclusion products, prebiotics, probiotics, herbs, etheric oils, acidic
compounds, and bacteriophages (Huyghebaert et al., 2010; Van Immerseel et al., 2009).
Of those proposed alternatives, both organic acids and probiotics work through similar
modes of action. Some probiotics, such as lactic acid producing bacteria (LAB) are
capable of improving the physiological and anatomical structure of the intestinal cell
wall, enhancement of immunological functions in the GIT, and the enhanced resistance to
enteropathogenic bacteria by producing short chain fatty acids (SCFAs), hydrogen
peroxide, and intermediary metabolites with antimicrobial activity (Huyghebaert et al.,
2010). Most organic acids consist of SCFAs which either lower the surrounding pH
directly or lower the internal pH of enteric bacteria without affecting the pH of their
surroundings (Fernández-Rubio et al., 2009). Thus, organic acids and probiotics are
similar in action because probiotics are capable of producing SCFAs similar to the actual
organic acid feed supplement.
Although both organic acid and LAB supplements are proposed alternatives and
share similar modes of action through the use of SCFAs, it is necessary to evaluate both
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for their effectiveness against pathogenic bacteria such as Salmonella. Due to the
complex nature of microflora present in the GIT and it’s ability to develop immune
responses to pathogens, in vivo studies would not provide the necessary conditions to
evaluate the effectiveness of the antibiotic alternatives, organic acids and LAB, on
pathogenic bacteria. Thus, the objective of the current study was to determine the in vitro
effects of two antibiotic alternative supplements against varying concentrations of an
antibiotic resistant strain of Salmonella Heidelberg over an 8 h time period.
Materials and Methods
Treatments
There were 3 treatments used in the current study to evaluate the effect of an
encapsulated butyric acid product (EBA) and a lactic acid producing bacteria product
(LAB; PrimaLac®) on varying concentrations of antibiotic resistant S. Heidelberg at 0, 2,
4, 6, and 8 h. The first treatment consisted of the control (S), nalidixic resistant S.
Heidelberg at 105, 106, and 107 CFU/mL. The second two were combinations of the
control (S) and the antibiotic alternatives, encapsulated butyric acid (S+B and S+P,
respectively).
The control, S, was comprised of nalidixic resistant S. Heidelberg at 105, 106, and
107 CFU/mL. A 12 h culture of S. Heidelberg was serially diluted to obtain the previously
mentioned concentrations. The other two treatments, S+B and S+P, consisted of the
individual products and the nalidixic resistant S. Heidelberg, which were combined by
adding 1 mL of S. Heidelberg to 9 mL of reconstituted products.
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Antibiotic Resistant Salmonella Heidelberg
An antibiotic resistant strain of Salmonella Heidelberg was obtained from Moore
et al. (2016) to demonstrate the effect the two antibiotic alternatives, EBA and LAB, have
on pathogenic bacteria. Nalidixic acid resistant Salmonella Heidelberg (NA19) was
obtained from a frozen stock maintained at - 80°C. One loop of frozen stock of S.
Heidelberg was streaked to isolated on Tryptic Soy Agar (TSA; BD Difco, Franklin
Lakes, NJ) containing nalidixic acid (5000µg/mL; Sigma Aldrich, St. Louis, MO) and
incubated (VWR™ International, 1535 incubator, Cornelius, OR) at 37° C for 24 h under
aerobic conditions. From the streaked TSA plates, one colony was isolated and inoculated
into fresh nutrient broth containing 5000µg/mL of nalidixic acid (Sigma Aldrich, St.
Louis, MO) and incubated aerobically for 24h at 37°C. The resulting culture was utilized
as the stock culture for nalidixic acid resistant S. Heidelberg in the study.
One mL of the resulting culture was transferred into 9 mL of fresh nutrient broth
and nalidixic acid (5000 µg/mL) to determine the growth curve and concentration of
nalidixic acid resistant S. Heidelberg. At 0, 12, and 24 h of incubation, 100 µl of the S.
Heidelberg culture was serial diluted into 2 mL microcentrifuge tubes containing 900 µl
of 1 X PBS. 100 µl of the resulting serial dilutions at each time interval was spread plate
onto TSA containing nalidixic acid (5000 µg/mL) and incubated aerobically for 24 h at
37°C. The resulting growth was counted and log transformed. It was determined that after
12 h of incubation, S. Heidelberg was at a concentration of 107 CFU/mL. The starter
culture of nalidixic resistant S. Heidelberg was maintained at this concentration for the
remainder of the study and used as the starter culture.
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Preparation of Treatment
Due to the encapsulation of EBA (ButiPEARL™, Kemin, Des Moines, Iowa), 30
min prior to the onset of the study, 1 g of EBA was reconstituted into 9 mL of fresh
nutrient broth (Difco BD™, Franklin Lanes, NJ). The culture was vortexed for 5 minutes
continuously to release the butyric acid from encapsulation.
The LAB, a commercially available dehydrated fermentation product
(PrimaLac®, Star-Labs, Clarksdale, Montana), consisted of the following LAB:
Lactobacillus acidophilus, Lactobacillus rhamnosus, Bifidobacterium thermophilum, and
Enterococcus faecium. Due to the fermented state of the product, LAB was cultured prior
to the initiation of the trial. 1 g of the LAB product was reconstituted in 9 mL of fresh
nutrient broth (Difco BD™, Franklin Lanes, NJ) and incubated (VWR™ International,
1535 incubator, Cornelius, OR) for 24 h at 37°C under anaerobic conditions. An
anaerobic environment was obtained using a Mart anaerobic canister, catalyst, and
Anoxomat Mart II system (Mart Microbiology B. V., Netherlands). Following the 24h
incubation, 1 mL of the resulting culture was transferred to 9 mL of fresh nutrient broth
at the onset of each trial for the starter culture (0 h). The reconstitution and transferring of
LAB was utilized to isolate the beneficial bacteria provided in the fermented product and
eliminate other ingredients such as rice hulls and calcium carbonate.
Utilizing the previously mentioned method, a growth curve and concentration of
bacteria was obtained per gram of LAB product. A 100 µl volume of the culture was
serially diluted into 2 mL microcentrifuge tubes (USA Scientific, Irvine, CA) containing
900µl of 1x Phosphate Buffered Saline (PBS; Difco BD™, Franklin Lanes, NJ). From
those dilutions, 100 µl were spread plated onto Tryptic Soy Agar (Difco BD™, Franklin
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Lanes, NJ) at 0, 12, 24, and 48 h. Plates were incubated under anaerobic conditions with
the use of a Mart anaerobic canister, catalyst, and Anoxomat Mart II system (Mart
Microbiology B. V., Netherlands) at 37°C for 48 h. Colonies were counted and log
transformed. At 48 h of anaerobic incubation, the concentration of bacteria within the
LAB product was determined to be approximately 108 CFU/mL (Table 3.1).
Microbial Analysis
With pathogenic bacteria commonly colonizing the GIT of poultry, the fecal-oral
route is a common mode of transmission (Porter, 1998). Thus, in the current study, the
mean passage rate of a common corn – soybean meal diet with DDGs was the basis for
the time frames chosen to evaluate the products against S. Heidelberg. The mean passage
rate of a corn – soybean meal diet with DDGs is approximately 5.58 h, however due to
variation in digestion, 0, 2, 4, 6, and 8 h of incubation was chosen (Rochell et al., 2012).
Due to anaerobic conditions of the GIT, the cultures were all incubated under anaerobic
conditions through the use of the Anoxomat Mart II system (Mart Microbiology B. V.,
Netherlands) at 37°C.
At 0, 2, 4, 6, and 8 h of incubation, S, S+B, and S+P were removed from
incubation. During these times, cultures were tested for pH and for Salmonella growth.
pH was tested for individual products (B and P) and S, S+B, and S+P using an Accumet
Excel XL60 probe (Fisher Scientific, Waltham, MA). Measured pH was not statistically
analyzed, as separate cultures were utilized for pH and microbial analysis to prevent cross
contaminate.
Following the removal of cultures from incubation at 0, 2, 4, 6, and 8 h, cultures
were vortexed thoroughly and 100 µl of the culture was serially diluted in 2 mL
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microcentrifuge tubes containing 900µl of 1 X PBS. Serial dilution was performed in
triplicate for replication. Upon the completion of serial dilution, 100 µl was spread plated
on TSA plates containing nalidixic acid (5000 µg/mL) in duplicate. Plates were
immediately flipped. Due to the aerobic nature of Salmonella Heidelberg, plates were
incubated aerobically for 24 h at 37°C. Single colonies were recorded from viable plates
containing between 30 and 300 colonies. Recorded colonies were log transformed and
statistically analyzed. The overall study was replicated three times for replication.
Statistical Design
Log transformed counts were analyzed using a randomized complete block design
with split plot over incubation time. Proc GLM was utilized in SAS 9.4 to analyze the
data (SAS, 2014). Means were separated using Fisher’s protected LSD when P ≤ 0.05
(Steel and Torrie, 1980).
Results
At a 105 CFU/mL starting concentration of nalidixic resistant Salmonella
Heidelberg (control) significantly grew over an 8 h period of time, exceeding 107
CFU/mL, and plateauing at 6 to 8 h of incubation (Figure 3.1; P≤0.0001). Salmonella
Heidelberg grown in the presence of EBA (S+B), was significantly reduced at 0, 2, 4, 6,
and 8 h of incubation compared to the control. Throughout time, S+B growth did not
exceed 4.7 log CFU/mL, which was obtained at 0 h. S+B growth was substantially
decreased from 0 to 2 h, 2 to 4 h, and was maintained from 4 to 8h. After 8 h of
incubation, EBA reduced Salmonella over 3 log CFU/mL. Unlike S+B, Salmonella
grown in the presence of LAB (S+P) maintained growth from 0 to 8 h. As well, S+P
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growth was significantly lower compared to the control from 2 to 8 h of incubation. At 8
h of incubation, LAB reduced Salmonella Heidelberg growth around 1 log CFU/mL.
At a 106 CFU/mL starting concentration of nalidixic resisistant Salmonella
Heidelberg, the control experienced a significant increase of 2 logs CFU/mL from 0 8 h
of incubation (Figure 3.2; P≤0.0001). S+B growth was significantly lower than the
control over an 8 h incubation period. S+B growth maintained growth around 5 logs
CFU/mL. At 8 h of incubation, S+B growth was 3 logs CFU/mL lower than the control.
S+P growth was also significantly less than the control throughout the 8 h incubation
period. However, over time, S+P growth increased over the 8 h incubational period. At 8
h, S+P growth was only 1 log CFU/mL lower than the control.
At a 107 CFU/mL starting concentration of nalidixic resistant Salmonella
Heidelberg, the control increased over an 8 h period of incubation to 108 CFU/mL
(Figure 3.3; P≤0.0001). S+B growth was comparatively lower than the control over an 8
h period. S+B growth was maintained from 0 to 2 h, reduced from 2 to 6 h, and
maintained from 6 to 8 h of incubation. At 8 h of incubation, S+B growth was 2 logs
CFU/mL lower than the control. S+P growth was lower compared to the control from 0
to 8 h of incubation. At 8 h of incubation, S+P growth was around 1 log CFU/mL less
than the control. As well, S+P growth was not significantly different from S+B growth
from 0 to 2 h of incubation, however, unlike S+B, S+P growth increased from 2 to 6 h of
incubation. From 0 to 8 h of incubation, S+P growth increased by 1 log CFU/mL.
Although pH was measured for each of the treatments at all initial concentrations
of Salmonella, 105, 106, and 107 CFU/mL, pH did not differ greatly between the control,
the products alone, or Salmonella grown in the presence of the products (Table 3.4-5),
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data not analyzed). As well, pH did decrease over an 8 h period of time, as the pH of all
treatments lowered on average from a pH of 7.03 to 6.75. Decrease in pH was greater
seen in the control at all concentrations, except 107 CFU/mL. At the initial concentration
of 107 CFU/mL, P and S+P resulted in a greater decrease of pH over an 8 h period of
incubation. S+P obtained an initial pH of 7.03 and after 8 h of incubation, decreased the
pH to 6.54.
Discussion
Salmonella, a leading cause of foodborne illness and poultry welfare concern, is
naturally present in the GIT of warm blooded mammals (Holt et al., 2000). With
Salmonella being naturally present with poultry, interventions need to be put in place in
pre-harvest facilities. Such interventions proposed are feed supplements which directly
affect the GIT. These supplements may have several modes of action; however, it is
imperative that they are capable of eliciting a detrimental effect on pathogenic bacteria.
Although several supplements exist, LAB and organic acids show promise as pre-harvest
interventional methods. In the current study, evaluating the efficacy of LAB and butyric
acid dietary supplements on reducing Salmonella Heidelberg at starting concentrations of
105, 106, and 107 CFU/mL, both products proved to decrease Salmonella throughout an 8
h period compared to Salmonella grown alone.
Both EBA and LAB were able to reduce the antibiotic resistant Salmonella
Heidelberg, in vitro. However, both feed additives were most effective at reducing
Salmonella Heidelberg at an initial concentration of 105 CFU/mL. Both EBA and LAB
may be better equipped to handle low dose Salmonella infections. Other research
investigating butyric acid and its derivatives, noted that at, butyric acid treatments were
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less effective at reducing proliferation of C. perfringens at a high dose (107 CFU/mL)
compared to the reduction seen at the inoculation of a low dose of C. perfringens (105
CFU/mL) (Namkung et al., 2011). Other research looking at various species and strains
of LAB, indicated the capability of LAB in reducing Salmonella proliferation in vitro at
both 105 and 106 CFU/mL (Dexian et al., 2012; Tsai et al., 2005). Although, in the
current study, both EBA and LAB were less effective at reducing Salmonella
proliferation at higher initial concentrations, it does not diminish their beneficial effect on
Salmonella reduction, in vitro.
Although both supplements have less effect on higher doses of Salmonella, it has
been seen that low doses of Salmonella have been connected to human and fowl typhoid
infections (Blaser and Newman, 1982; Christensen et al., 1996). Most human typhoidal
outbreaks are believed to be associated with high dose infections, however data
associated with typhoid outbreaks suggests that ingested doses were below 103 CFU.
Christensen et al. (1996) challenged 1 wk old White Leghorn cockerels with 0.1 mL of
Salmonella Gallinarum, equipped with Restriction Fragment Length Polymorphism
(RFLP) variants of S. Gallinarum, containing 108 CFU. Despite a higher challenge dose
being utilized, clinical signs of fowl typhoid in the spleen were noted at a much lower
dose of 104 CFU (Christensen et al., 1996). While EBA and LAB were less effective at a
higher initial concentration, both did significantly reduce Salmonella proliferation in
vitro, which may indicate that the two feed additives may be capable of decreasing the
incidences of low dose infection, such as human and fowl typhoid.
As stated previously, the range of Salmonella concentration was chosen to
determine the response of different feed additives on a high and low dose of Salmonella
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infection. The results indicated that both products were more effective at a low dose
infection of Salmonella, however due to the nature of the supplements being supplied in
poultry diets, inclusion from 1st day of hatch would be recommended. Research of
Higgens et al. (2010) demonstrates the efficacy of LAB at d of hatch, then at the second d
of life. As well, the time of administration of the LAB and the time of the challenge have
an effect on the LAB’s effectiveness on pathogen reduction, with early LAB
administration being more effective (Higgens et al., 2010). Supplied at first day of hatch,
these additives, EBA and LAB, may have the potential to prevent Salmonella
proliferation from reaching a higher concentration in which these products cannot handle.
Both EBA and LAB reduced nalidixic resistant Salmonella Heidelberg when
cultured simultaneously; however, LAB was unable to sustain the reduction of
Salmonella growth throughout 8 h period. This may have occurred due to the specific
LAB being utilized in the study. Other LAB, such as Lactobacillus reuteri ATCC 55730
and L22, have been shown to sustain a reduction of Salmonella pullorum ATCC 9120
over a 24 h incubation time (Dexian et al., 2012). In a study investing the effect of
Lactobacillus acidophilus LAP5 and Lactobacillus fermentum LF33 on Salmonella
typhimurium I50 invasion of cultured INT-407 cells, both LAP5 and LF33 were capable
of reducing S. typhimurium in co culture at 3 and 1.5 logs respectively (Tsai et al., 2005).
The species and strains of LAB utilized in LAB may not be as bactericidal as those
previously listed as not all LAB have equivalent antimicrobial properties against
Salmonella (Yokokura, 1997; Kim et al., 2006). However, the LAB in LAB may have
more potential in vivo then as seen in the current in vitro study. The LAB species in LAB
are capable of interacting with the host to promote competitive exclusion and enhance
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immune response which could result in greater reduction of pathogens (Fuller, 1989;
Patterson and Burkeholder, 2003; Rolfe, 2000).
As stated previously, both products were shown to be capable of decreasing
Salmonella through time compared to the control, but EBA was capable of sustaining the
reduction of Salmonella over an 8 h incubation period, in vitro. This may be a result of
the encapsulation of butyric acid in EBA. Previous research has noted the benefit of
coating or encapsulating butyric acid, as it enables butyric acid to dissociate in the lower
GIT, rather than the crop (Fenández-Rubio et al., 2009). This capability may have
sustained the bactericidal effect EBA had on Salmonella in the current study.
Another bactericidal factor of both products is their potential to reduce pathogens
through the acidification of the surrounding and intracellular pH. In the current study, the
pH of the co cultures of S+B and S+P did not reduce the mediums pH below 6.5. And
though pH was monitored in the current study, pH was not adjusted to mimic the
conditions of the GIT. Previous research has indicated that both butyric acid and LAB are
more effective at reducing Salmonella spp. at a more acidic pH (Goepfert and Hicks,
1969; Park et al., 2005; Panchayuthapani et al., 1995). Further, other research has
demonstrated the ability of coated butyric acid to reduce S. Typhimurium to be enhanced
in the presence of lipase, as lipase is capable of inducing a lower pH, in vitro (Namkung
et al., 2011). Thus, both products may be more effective, in vivo, when both travel the
GIT and are introduced to the low pH of the proventriculus and lipase in the duodenal
loop.
EBA and LAB possess similar modes of action through use of SCFAs, such as
altering the pH of the GIT. However, both exhibit other potential benefits in vivo that
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may lead to further reduction of pathogenic bacteria and increased livability of poultry
bacteria (Gunal et al. 2006; Vlademirova and Sourdjiyska, 1996; Jin et al., 1998; Vogt et
al., 1981; Runho et al., 1997). Thus, the authors would like to compare these feed
additives, EBA and LAB, in vivo. Investigate both products on their effects on growth
performance, immune response, GIT physiology and morphology, and the GIT
microflora.

Conclusion
In conclusion, both EBA and LAB alone have the potential to decreases nalidixic
resistant Salmonella Heidelberg, in vitro, with both being more effective at 105 CFU/mL.
As well, EBA has the potential to sustain the reduction of S. Heidelberg throughout 8 h,
whereas, LAB was not. However, further studies should be conducted to identify the
products efficacy on pathogenic reduction in vivo.
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Tables
Table 3.1
Hour
0
12
24
48

Table 3.2

Growth curve of LAB product after reconstitution.
Total LAB (CFU/mL)
6.00
7.57
7.86
7.86

pH of treatments over an 8 hr period when an antibiotic resistant
Salmonella Heidelberg is at a concentration of 105 CFU/mL.1
pH*
4h

Time
0h
2h
6h
8h
Treatment
S
7.13
7.11
6.91
6.67
6.67
B
7.05
6.81
6.63
6.71
6.77
P
6.96
6.64
6.52
6.66
6.74
S+B
7.05
6.81
6.67
6.74
6.79
S+P
6.96
6.66
6.53
6.69
6.74
*pH was not statistically analyzed
1
Treatments: S, nalidixic resistant Salmonella Heidelberg as the control; B, EBA; P,
LAB; S+B, coculture of nalidixic resistant Salmonella Heidelberg and EBA; S+P
coculture of nalidixic resistant Salmonella Heidelberg and LAB.
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Table 3.3

pH of treatments over an 8 hr period when an antibiotic resistant
Salmonella Heidelberg is at a concentration of 106 CFU/mL.1
pH*
4h

Time
0h
2h
6h
8h
Treatment
S
7.14
7.06
6.78
6.60
6.71
B
7.06
7.00
6.98
6.86
6.85
P
6.92
6.95
6.83
6.62
6.41
S+B
7.03
6.99
6.99
6.84
6.84
S+P
6.94
6.97
6.87
6.56
6.80
*pH was not statistically analyzed
1
Treatments: S, nalidixic resistant Salmonella Heidelberg as the control; B, EBA; P,
LAB; S+B, coculture of nalidixic resistant Salmonella Heidelberg and EBA; S+P
coculture of nalidixic resistant Salmonella Heidelberg and LAB.
Table 3.4

Time
Treatment
S
B
P
S+B
S+P

pH of treatments over an 8 h period when an antibiotic resistant Salmonella
Heidelberg is at a concentration of 107 CFU/mL.1

0h

2h

pH*
4h

7.20
7.05
6.92
7.06
7.03

6.94
6.99
6.87
7.02
6.92

6.75
6.95
6.70
7.00
6.81

6h

8h

6.90
7.09
6.83
6.81
6.8

6.99
6.94
6.79
6.84
6.54

*pH was not statistically analyzed
1
Treatments: S, nalidixic resistant Salmonella Heidelberg as the control; B, EBA; P,
LAB; S+B, coculture of nalidixic resistant Salmonella Heidelberg and EBA; S+P
coculture of nalidixic resistant Salmonella Heidelberg and LAB.
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Figure 3.1

The effect of EBA and LAB on Salmonella Heidelberg at 105 CFU/mL.1,2
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Figure 3.2

The effect of EBA and LAB on Salmonella Heidelberg at 106 CFU/mL.1,2
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The effect of EBA and LAB on Salmonella Heidelberg at 107 CFU/mL.1,2
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CHAPTER IV
EFFECTS OF AN ENCAPSULATED BUTYRIC ACID AND LACTIC ACID
PRODUCING BACTERIA USED ALONE OR IN COMBINATION
ON 57 D BROILER PERFORMANCE AND PROCESSING
Abstract
Separately, lactic acid producing bacteria (LAB) and organic acids have been
found to improve broiler performance when provided in diets. However, the combination
has not been explored in literature. Thus, the objective of this study was to determine if
the inclusion of an organic acid, LAB, or the combination of both products influence
broiler performance when added to the diet throughout a 57d growout. The 5 dietary
treatments included a basal diet (C), C+an encapsulated butyric acid (B), C+LAB (P),
C+an encapsulated butyric acid and LAB (B+P), and C+an antibiotic, bacitracin
methylene disalicylate (A). All additives were included based on manufacturer
recommendations. On d 0, 1,440 day old male Ross×Ross 708 chicks were obtained and
placed into 80 floor pens. (16 replicates, 18 birds per pen). Birds were provided feed and
water ad libitum. Performance data were collected at 0, 14, 28, 45, and 56d. On d14,
birds were challenged with a 10× dose of a live coccidiosis vaccine. Processing data were
collected on d57. Data were analyzed using a randomized complete block design and
means were separated using Fisher’s protected LSD when P ≤ 0.05. No live performance
differences were observed on d0-14 or on d0-56 of the experiment (P>0.05). However,
differences at d0-45 demonstrated that birds fed diets containing P and A diets had
increased BW gain (BWG) compared to those fed B+P and C (P=0.009). Additionally,
birds fed diets with P or A tended to have lower d0-45 FCR (P=0.07) compared to birds
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fed C. Also, d28-45 mortality was significantly reduced when birds were fed diets
containing A, B, P, or B+P, as compared to birds fed C (P=0.03). Significance was not
found for most of the measured processing characteristics (P>0.05); however, wing yield
was greater for birds fed diets with P compared to those fed B and C, but were similar to
birds fed B+P and A (P=0.03). Although no differences were observed from d0-56, the
current study demonstrates the potential efficacy of using P to replace A in commercial
diets, as birds fed P and A performed similarly from d0-45. Also, feeding birds B+P did
not prove to be as effective in improving broiler performance, as there was no FCR or
BWG benefit when compared to birds fed C alone.
Introduction
For the past 50 years, it has been common to utilize antibiotics in poultry diets; to
not only increase the performance of broilers, but also maintain a healthy flock.
However, due to consumer pressure and recent legislature, antibiotic growth promoters
(AGPs) have begun to be phased out of most commercial poultry diets. Throughout the
world, there is growing concern among poultry consumers of the potential ability of
pathogens to become antibiotic resistant through the use of AGPs. This concern has been
a major contributor of the movement to create AGP free poultry diets around the world
(Castanon, 2007). Recent legislature in the European Union has made the E.U.’s poultry
industry completely AGP free as of January 1, 2006 (Castanon, 2007). In attempt to
maintain performance and bird health, the poultry industry has sought out alternatives to
AGPs. Such alternatives include: prebiotics, probiotics, acidic compounds, competitive
exclusion products, and bacteriophages (Van Immerseel et al., 2009).
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Alternatives such as acidic compounds and probiotics utilize organic acids to
improve the conditions of the gastrointestinal tract (GIT) by reducing the colonization of
pathogenic bacteria. Literature has supported the supplementation of organic acids as the
choice antibiotic replacement in poultry diets (Dibner and Buttin, 2002; Dibner, 2003).
These acidic compounds consist mainly of short chain fatty acids, which either lower the
surrounding pH directly, or lower the internal pH of enteric bacteria without affecting the
pH of their surroundings (Fernández-Rubio et al., 2009). Lactic acid, a type of organic
acid, is produced in small amounts by lactic acid producing bacteria (LAB), which are
considered probiotics, however, as previously mentioned share similar properties with
acidic compounds (Huyghebaert et al., 2010). LAB have also demonstrated the potential
to not only mitigate colonization by pathogens, but improve the integrity of the GIT,
enhance immune functions, and improve growth performance (Bai et al., 2013; Gaggia et
al., 2010; Jin et al., 1996; Kabir et al., 2004).
Though both acidic compounds and LAB utilize organics acids to improve the
welfare of poultry and enhance their performance, but little is known on how these acidic
compounds directly affect the colonization of LAB. Previous research conducted by
Thompson and Hinton, demonstrated a reduction of lactic acid present in the crop after
the utilization of Bio-Add in the diet, concluding that the use of organic acids either
inhibits or destroys LAB (Thompson and Hinton, 1997). This reduction of LAB through
the utilization of organic acids has also been found by others (Impey and Mead, 1989;
Hume et al., 1993). Research involving organic acids being orally gavaged into male
broiler chicks resulted in a decrease of lactic acid in the foregut, liver and serum after 60
min exposure (Hume et al., 1993). As well, the in vitro addition of 10 g/kg of formic acid
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into a mixture consisting of Salmonella and Lactobacilli resulted in the death of all
organisms (Impey and Mead, 1989). If acidic compounds reduce LAB present in the GIT
of poultry in vivo, then it would invalidate its usefulness to the industry, as LAB are an
essential to establish a population of beneficial bacteria in the GIT.
As the GIT of poultry are assumed to be sterile prior hatch, the initial colonization
of bacteria in the GIT of chicks is critical (Kenworthy and Crabb, 1963). Because of
industry practices, eggs are removed from farms and hatched in commercial hatcheries, a
sterile environment. This allows for a more controlled process; however, it also makes
chicks more susceptible to pathogenic bacteria, as normal microflora are not present.
Almost immediately after hatch, chicks are susceptible and colonized by bacteria from
the diet and environment. At 5 – 6 hr (post-birth), an animal’s feces are colonized with up
to 109 to 1010 cfu/g of bacteria, with intestinal microflora being fully established by 2 – 3
wk of age (Snel et al., 2002). For a reduction in the incidences of pathogenic colonization
of poultry to occur, beneficial microflora must be established early and maintained. Thus,
the inclusion of organic acids may disrupt the establishment of LAB in chicks, leaving
the chick more susceptible to pathogenic bacteria.
Both organic acids and LAB have been accepted as alternatives to AGPs;
however, there is a need to investigate which alternative promotes better growth
performance of commercial broilers. As well, further research needs to address how
organic acids affect the colonization of beneficial bacteria, such as LAB. Thus, the
objective of this study was to determine the effect of organic acids, probiotics (LAB), and
their combination on performance and processing attributes in broilers through a 57 d
growout.
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Materials and Methods
Bird Husbandry
On d of hatch, 1,440 male Ross × Ross 708 broiler chicks were received from a
local commercial hatchery. The chicks were vaccinated for Marek’s disease, Newcastle,
and Gumboro disease. Birds were randomly placed in 80 floor pens with 18 birds per pen
(5 treatments, 16 replicates). Stocking density at placement was 0.062 sq. m./bird and
increased to 0.074 sq. m./bird by d 14. All birds were raised in floor pens; each pen
being comprised of a hanging feeder, three nipple drinkers, and used litter from a
commercial broiler house. Birds were supplied with water and feed ad libitum.
A photoperiod of 24 L:0 D was utilized from d 0 to 7, as well as a 20 L:4 D
photoperiod from d 8 to 57. At d 0, lighting was maintained at full intensity until d 10
where lighting was incrementally decreased to 2.5 lux and maintained from d 18 until the
end of the trial. The ambient temperature of the house was maintained at 32.2°C on d 0
and incrementally decreased until 16.1°C was obtained on d 49.
Birds were raised according to the husbandry practices recommended by Aviagen
(Aviagen, 2014). All animals in this trial were treated in compliance with the Guide for
the Care and Uses of Agriculture Animals in Researching and Teaching (Federation of
Animal Science Societies, 2010).
Diet Preparation
Four diet phases were formulated utilizing a least cost-industry relevant diet
consisting primarily of corn, soybean meal, dried distiller’s grains, and poultry fat. All
diets were formulated to meet or exceed the NRC and Aviagen guidelines (NRC, 1994;
Aviagen, 2014) for each dietary phase (Table 4.1). One common basal mash diet was
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initially batched, less the inclusion of dietary treatments, at the Poultry Research Unit at
Mississippi State University for the starter grower and finisher diets. Basal diets were
mixed for 5 min dry, and 10 min wet (after the addition of poultry fat) utilizing a vertical
screw mixer (Jacobson).
The inclusion of dietary treatments, encapsulated butyric acid (EBA), a LAB,
combination of EBA and LAB, and antibiotic, were made just prior to pelleting at the
USDA Poultry Research Unit in Starkville, Mississippi, a feed mill specialized in
manufacturing of experimental diets. The treatments were included in the diet according
to the manufacturer’s recommendations and sand was used as diluent to a total inclusion
rate of 1.5 g/kg (Table 4.2). There were 5 treatments essentially consisting of a basal diet
designated as the control (C), the basal diet with the inclusion of EBA (0.5 g/kg;
ButiPEARL, Kemin, Des Moines, Iowa) (B), the basal diet with the inclusion of LAB
(1.0 g/kg; PrimaLac, Star-Labs, Clarksdale, Montana) (P), the basal diet with the
inclusion of both EBA (0.5 g/kg) and LAB (1.0 g/kg) (B+P), and the basal diet with an
antibiotic, bacitracin methylene disalicylate (0.5 g/kg; BMD-50, Alpharma, Fort Lee,
NJ.) (A). ButiPEARL™, an encapsulated butyric acid product is encapsulated using
MicroPEARLS spray freezing process, which enables the product to maintain a high
content of butyric acid (50%) and travel further down the GIT. PrimaLac® is a direct fed
microbial consisting of Lactobacillus acidophilus, Lactobacillus rhamnosus,
Bifidobacterium thermophilum, and Enterococcus faecium (PrimaLac, Star-Labs,
Clarksdale, Montana). Preliminary research indicated that 1 g of PrimaLac® contains
7.97 log CFU/mL of LAB after 8h of growth in vitro. For each treatment, dietary
additives (B, B+P, P, and A) were mixed with approximately 11 kg of basal diet for 5
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min in a small horizontal mixer (11.34 kg capacity). Immediately following, diets were
mixed for 4 min in a horizontal ribbon mixer (907 kg capacity), prior to pelleting.
All diets were pelleted using a 40 HP CPM with a 38.1 × 4.76 mm pellet die,
regardless of phase. The four dietary phases consisted of: a starter (d 0-14), grower (d 1428), finisher I (d 28-45), and finisher II (d 45-56). The starter was provided as crumbles.
Pellets were introduced at d 14 and fed for the remainder of the study.
Coccidia Challenge
On d 14, all birds were subjected to a coccidia challenge comprised of a 10× dose
of a commercially available coccidiosis vaccine with live oocytes of the following
species of coccidia: Eimeria acervulina, Eimeria maxima, Eimeria maxima MFP,
Eimeria mivati, and Eimeria tenella (Coccivac®-B52, Intervet Inc.). The 10× dose was
orally gavaged directly into the crops of 14 d old chicks regardless of treatment. Only
healthy birds were subjected to challenge. Birds were not evaluated for lesion scores, as
the primary goal of this challenge was to help illicit response from tested products.
Growth Performance and Carcass Characteristics
On day 0, 14, 28, 45, and 56, measurements were collected to determine body
weight, feed intake, and feed conversion ratios. On those days, feeders were pulled 4 to 6
h prior to weighing; the feeders and bird weights were recorded on a per pen basis. Body
weight gain (BWG), feed intake (FI), and feed conversion ratio (FCR) were calculated at
each age interval. Mortality was recorded daily and FCR was adjusted using mortality
weight. Carcass yield was determined on d 57 of the trial. Four birds from each pen were
randomly selected and processed at the Mississippi State University Poultry Science Pilot
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processing facility, located on South Farm, Starkville, MS. Carcass, fat pad, boneless,
skinless breast, tender, wing, thigh, and drumstick weights were recorded to calculate
yield.
Statistical Analysis
All data were analyzed using a randomized complete block design and analyzed
using PROC GLM of SAS 9.4 (SAS, 2014). Means were separated using Fisher’s
protected LSD and were considered significant at P ≤ 0.05 (Steel and Torrie, 1980).
Results and Discussion
With the removal of antibiotics weighing heavily on the poultry industry, it is
imperative to determine an effective alternative, capable of maintaining broiler
performance and health. Bacitracin, a commonly used antibiotic in the industry to control
Clostridium perfringens proliferation and prevent Necrotic Enteritis, was considered a
positive control or industry standard in the current study (A) (Nairn and Bamford, 1967).
The negative control was void of any antibiotic or antibiotic alternative (C). The use of
LAB and organic acids have been shown to be valid alternatives to AGPs, capable of
improving broiler performance, reducing pathogenic bacteria and protecting against
coccidiosis, however little is known about the effects of their combination. (Gunal et al.
2006; Vlademirova and Sourdjiyska, 1996; Jin et al., 1998; Vogt et al., 1981; Runho et
al., 1997; Shobha & Ravindranath, 1991; Garcia et al., 2007; Abbas et al., 2011; Dalloul
et al., 2005). Thus, the antibiotic alternative treatments, EBA, LAB and their
combination, were evaluated for their efficacy on improving FI, BWG, FCR, mortality,
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and processing yields, under challenged conditions, compared to birds fed an industry
standard (A) and untreated diet (C).
In the current study, no differences in live performance among treatments were
observed from d 0 to 14 or d 46 to 56 (P > 0.05) (Table 4.3). The lack of differences
observed from d 0 to 14 may be in part a result of the challenge conditions, as birds were
not subjected to a coccidia challenge until d 14. This challenge occurred after the feed
and weights were recorded. However, the dietary treatments elicited differences in
response during d 14 to 28 and d 28 to 45, the period directly after the challenge was
administered. Wang et al. (2016) also experienced similar results when challenging birds
with coccidia on d 14, where no differences in BW or FCR were observed from d 0 to 14.
Another study investigating the inclusion of LAB (PrimaLac) in the water or feed of
poultry under Eimeria challenge conditions also demonstrated no differences from d 0 to
14 in BWG or FCR (Giannenas et al., 2014). As well, Abudabos (2012) when
challenging birds with a 10× dose of a live anticoccidial vaccine and C. perfringens,
observed no differences in live performance from d 0 to 16 among the positive and
negative control, Enramycin diet, LAB (PrimaLac) diet, or LAB (PrimaLac) treated
water. The lack of differences from d 45 to 56 may also be related to the challenge or
lack of challenge. Birds in the current trial may have overcome the challenge of a 10×
coccidia vaccine during the last feeder phase.
Because of the lack of differences shown from d 0 to 14 and d 45 to 56, BWG, FI,
FCR, and mortality were analyzed from d 0 to 45 and d 0 to 56. D 0 to 45 is indicative of
the normal time frame to produce a 3.2 kg male broiler (Aviagen, 2014). The United
States on average produces a 2.8 kg broiler (mixed sex), thus being appropriate for the
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U.S. industry (USDA, 2017). Whereas, d 0 to 56 is representative of a large broiler grown
for further processing (4.3 kg) (Aviagen, 2014). From d 0 to 45 differences were
observed in BWG, however, differences were not observed for any live performance
characteristics from d 0 to 56 (P>0.05; Table 4.4).
No significant differences were detected in FI (per pen), regardless of feeding
phase, however, BWG differences were detected on d 14 to 28, d 28 to 45, and d 0 to 45,
with a trend from d 45 to 56 (P=0.033, 0.020, 0.009, 0.058, respectively). Although
significant differences were not noted on d 0 to 14, the birds fed diets containing t A
demonstrated higher BWG than those fed C and B+P during d 14 to 28, d 28 to 45, and d
0 to 45. During those times, birds fed diets supplemented with A, B, and P were not
different. However, from d 14 to 28, d 45 to 56 (trend), and d 0 to 45, birds fed diets
containing A and P resulted in higher BWG compared to those fed diets containing B+P
and C, though, from d 28 to 45, broilers fed diets A and P demonstrated increased BWG
than those fed C. No significant differences were found for BWG from d 0-56, which
may have attributed to the lack of difference observed from d 0 to 14 and d 45 to 56.
Similar findings were noted by Giannenas et al. (2014,) who experienced higher BW and
BWG on d 21 and 42 in in birds fed diets containing LAB and birds fed diets containing
antibiotics as compared to the control. Previous research has also demonstrated that from
1 to 42 d of age, dietary EBA is capable of improving BWG compared to a control
(Kaczmarek et al. 2016). Although, birds fed diets containing EBA have seen to increase
BWG, birds fed with B in the current study performed similarly to those fed diets
containing C, B+P, and A. EBA and LAB fed individually, in previous and current
research, have shown positive effects on BWG. Thus, one may speculate that the
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combination of B and P would improve BWG. Previous research has demonstrated the
improvement of BWG of birds fed a combination of butyric acid glycerides (Baby C4)
and LAB (PrimaLac), as birds fed the combination performed comparatively to those fed
LAB (PrimaLac) alone and outperformed those fed the control (Taherpour et al., 2009).
In the current study, no positive benefits on BWG were demonstrated with the inclusion
of the combination of B+P into C diets.
With BWG being improved in birds fed diets containing A and P compared to
birds fed C, and FI not being affected regardless of dietary treatment, differences in FCR
among treatments would be expected. Differences in FCR were observed during d 14 to
28 (P=0.044) and a trend was observed from d 0 to 45 (P=0.069). From d 14 to 28, birds
fed diets containing B, B+P, P, and A demonstrated improved FCR as compared to birds
fed the control. However, the trend in FCR observed from d 0 to 45 resulted in birds fed
diets containing A or P converting less feed to gain than birds fed C. However, birds fed
with either A or P diets were not significantly different than those fed with diets
containing B or B+P. LAB administered alone to birds has been shown to improve FCR
of C. perfringens challenged broilers comparative to enramycin and outperform positive
and negative controls (Abudabos, 2012). Birds fed the inclusion of EBA at a rate of 0.2,
0.3, and 0.4% have been shown to demonstrate improved FCR as compared to birds fed
control and similar to those fed antibiotics (Waguespack Levy et al., 2015; Kaczmarek et
al., 2016).
Although previous research has demonstrated the positive effects of utilizing EBA
and LAB alone in diets and in combination, the diets containing the combination of B and
P performed similar to all other dietary treatments from d 14 to 28 and no significant
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difference from d 0 to 45 in FCR was established when compared to birds fed the control.
This is in agreeance with the hypothesis that the fed combination may not be beneficial to
broilers. Contrary to the results in the current study, a study conducted by Taherpour et
al. (2009), pertaining to birds fed the inclusion and combination of a prebiotic
(Fermacto), LAB (PrimaLac), and EBA (Baby C4), found no differences in FCR between
birds fed LAB, EBA, and combination of LAB and EBA dietary treatments at 42 d of
age. However, birds fed LAB, EBA, and their combination experienced better FCR than
the control treatment (Taherpour et al., 2009). Not unlike the study conducted by
Taherpour et al. (2009), the current study experienced no differences among birds fed
diets containing B and B+P from birds fed the control diet, however, birds fed diets with
P and A differed from those fed the control diet. The difference in FCR improvement
between the current study and the study conducted by Taherpour et al. (2009) may be a
result of the inclusion of an Eimeria challenge in the current trial. The dietary inclusion
of B and B+P may not be able to support the immune response against the challenge and
thus require more energy for maintaining the bird’s health and provide less energy for
improving broiler performance.
Differences in mortality were not observed from d 0 to 14, d 14 to 28, d 45 to 56,
d 0 to 45, and d 0 to 56 (P=0.795, 0.745, 0.898, 0.253, 0.299, respectively). Differences
in mortality were detected from d 28 to 45 (P=0.03; Figure 4.5). The birds fed the C diet
possessed higher percent mortality than all other treatments. Birds fed B, B+P, P, and A
did not differ in regard to percent mortality. In a similar study investigating the dietary
inclusion of LAB and an antibiotic under Eimeria infection, total mortality (d 0-42) was
seen highest in birds fed the control treatment, with birds fed diets containing LAB
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(PrimaLac) intermediate, and the antibiotic (Lasalocid) treatment experiencing the least
mortality (Giannenas et al., 2014). Contrary, the current study resulted in no differences
among birds fed feed additive treatments from those fed the antibiotic treated diet,
bacitracin methylene disalicylate. Previous research has demonstrated the inclusion of
EBA in diets to have no effect on mortality (Waguespack Levy et al., 2015; Leeson et al.,
2005). As well, the inclusion of LAB (PrimaLac) in water has shown no effect on
mortality when broilers were under stress from standard vaccination procedures
(Newcastle disease and infectious bursal disease; Talebi et al., 2008). Although birds fed
the dietary inclusion of EBA, LAB, and their combination did not differ from those fed
A, a decrease in mortality at is still beneficial to the industry.
Feed additive inclusion had no effect on the majority of the measured processing
characteristics; however, differences in carcass wing yield and wing yield relative to live
weight (%) were observed (P=0.030, P=0.015, Table 4.5-8). Wing yield was significantly
higher in broilers fed P treated diets when compared to birds fed diets containing C or B.
Further, wing yield of birds fed P were not significantly different from those fed diets
containing B+P or A. When comparing wing yield relative to live weight, birds fed diets
containing P increased wing yield (%) compared to those fed diets with A or B. Also,
birds fed diets with the inclusion of P, B+P, and C did not differ in wing yield relative to
live weight. A previous study demonstrated the efficacy of LAB (PrimaLac) inclusion in
increasing total carcass yield under a challenge of C. perfringens and performing
comparatively to birds fed diets supplemented with enramycin (Abudabos, 2012). As
well, birds fed EBA supplemented diets have demonstrated similar carcass weight and
breast yield (g) to birds fed diets supplemented with bacitracin, with increased yield
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being shown at a higher inclusion rate of EBA (Leeson et al., 2005). The current trial
resulted in birds fed diets with the inclusion of EBA and bacitracin with similar wing
yield relative to body weight. Also, the inclusion rate of EBA at 0.5 g/kg, may not be
sufficient enough to improve performance and processing characteristics in broilers,
although birds fed diets supplemented with EBA did perform similar to birds fed A.
Unlike live performance, birds fed B+P diets did improve wing yield and wing yield
relative to live weight comparative to those fed P alone. Conclusively, the current study
demonstrated that during a challenge of coccidiosis, LAB included in the diet is capable
of improving certain processing characteristics.
Conclusions
The current study demonstrated the efficacy of LAB as an alternative to
antibiotics, as birds fed diets supplemented with it were capable of performing
comparatively to those fed diets supplemented with BMD from d 0 to 45. Although birds
fed diets containing EBA did not improve performance, they did perform similar to those
fed diets containing LAB or BMD from d 0 to 45. However, diets supplemented with the
combination of EBA and LAB did not improve performance when compared to diets
containing EBA or LAB alone. Thus, the inclusion of the combination of organic acids
and Lactic Acid Producing Bacteria alone in poultry diets may not be beneficial to
performance of broilers. However, further research is necessary to understand the impact
the combination of these products have on the GIT of broilers in comparison to EBA and
LAB alone.
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Tables
Table 4.1

Composition of feed ingredients and calculated nutrient contents of basal
diets

Item
D 0 to 14
D 14 to 28
D 28 to 45
D 45 to 56
Ingredient1, %
Corn
58.453
63.660
72.944
76.681
Soybean Meal
32.464
23.628
17.636
16.369
cDDGS
3.000
5.000
2.1637
0.000
ProPlus 552
3.000
4.000
4.000
3.886
Poultry Fat
0.500
1.039
0.598
0.525
Defluorinated Phosphate
1.026
0.725
0.583
0.506
Calcium Carbonate
0.137
0.561
0.590
0.556
L-Lysine hydrochloride
0.233
0.344
0.332
0.316
DL-Methionine
0.304
0.293
0.252
0.235
Vitamin-Trace Min PM Nutrablend 30003
0.273
0.273
0.273
0.273
Sodium Bicarbonate
0.095
0.130
0.197
0.216
L-Threonine
0.084
0.091
0.085
0.080
Salt, NaCl
0.219
0.047
0.135
0.146
Quantum Blue4
0.030
0.030
0.030
0.030
Selenium Premix
0.022
0.022
0.022
0.022
HostazymX5
0.010
0.010
0.010
0.010
Sand/Treatment6
0.150
0.150
0.150
0.150
Nutrient Contents7
ME (Kcal/kg)
2,996
3,073
3,124
3,148
CP, %
22.805
20.255
17.357
16.381
Crude fiber, %
2.752
2.807
2.491
2.602
Crude fat, %
3.443
4.751
4.388
4.254
Ca, %
0.671
0.780
0.730
0.680
Available P, %
0.335
0.330
0.300
0.280
Na, %
0.196
0.136
0.176
0.176
Digestible lysine, %
1.200
1.100
0.940
0.890
Digestible methionine, %
0.601
0.559
0.488
0.460
Digestible TSAA, %
0.912
0.836
0.733
0.694
Digestible threonine, %
0.780
0.726
0.6298
0.596
1
Ingredient nutrient composition were analyzed before formulating the diet.
2
H.J. Baker’s ProPlus 55 Animal Protein Concentrate
3
Premix provided the following per kilogram of finished diet: manganese, 0.02 mg; zinc, 0.02 mg; iron,
0.01 mg; copper, 0.0025 mg; iodine, 0.0003 mg; selenium, 0.00003mg; folic acid, 0.69 mg; choline, 386
mg; riboflavin, 6.61 mg; biotin, 0.03 mg; vitamin B6, 1.38 mg; niacin, 27.56 mg; pantothenic acid, 6.61
mg; thiamine, 2.20 mg; menadione, 0.83 mg; vitamin B12, 0.01 mg; vitamin E, 16.53 IU; vitamin D3,
2,133 ICU; vitamin A, 7,716 IU (NB3000, Nutrablend, Neosho, MO).
4
Quantum Blue provided the following per kilogram of finished diet: not less than 10,000,000 FTU of
Phytase (Quantum Blue, AB Vista, Marlborough, Wiltshire).
5
Hostazym X provided the following per kilogram of finished diet: Endo-1,4-beta-xylanase, 15,000,000
EPU.
6
Experimental Additives [ButiPEARL (.5 g/kg of finished feed), PrimaLac (1.0 g/kg of finished feed),
combination of ButiPEARL and PrimaLac (0.5 g/kg and 1.0 g/kg of finished feed, respectively), and
bacitracin methylene disalicylate (0.5 g/kg of finished feed)] were added in replacement of sand.
7
Nutrient contents were calculated on a dry matter basis.
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0.777

0.516

0.506

0.519

0.006

0.714

B+P

P

A

SEM
Pvalue

8.119

8.003

8.156

0.353

0.017

1.299

1.241

1.276

1.280

1.269

Feed
conversion
ratio

0.795

0.537

1.042

0.695

1.042

0.348

0.348

Mortality

0.633

0.028

1.661

1.673

1.633

1.641

1.688

Feed
Intake
(kg)

1.619
1.600

a

0.033

0.015

1.006

0.044

0.030

b

b

ab

0.991

1.630b

0.964bc

1.634

b

abc

0.970

1.720a

Feed
conversion
ratio

0.942c

BW
gain
(kg)

D 14 to 28

0.745

1.052

1.378

2.947

1.250

2.223

2.529

Mortality

0.765

0.035

3.249

3.215

3.208

3.223

3.197

Feed
Intake
(kg)

a

0.020

0.029

3.149

3.136

ab

3.045c

3.100

abc

3.057bc

BW
gain
(kg)

0.736

0.211

1.900

1.880

1.919

1.903

1.869

Feed
conversion
ratio

D 28 to 45

b

0.033

0.886

0.961

1.704

b

0.481b

0.513

b

4.409a

Mortality

0.796

0.053

3.109

3.111

3.057

3.047

3.118

Feed
Intake
(kg)

0.058

0.037

1.238

1.213

1.190

1.207

1.333

BW
gain
(kg)

0.194

0.044

2.300

2.318

2.326

2.232

2.204

Feed
conversion
ratio

D 45 to 56

0.898

0.883

10.500

10.109

9.724

9.341

10.040

Mortality

Experimental diets: control diet (negative control without any additives); a EBA supplemented diet (B, the basal diet with an
inclusion of 0.5 g/kg of ButiPEARL); a LAB supplemented diet (P, the basal diet with an inclusion of 1.0 g/kg of PrimaLac); a diet
consisting of both EBA and LAB supplements (B+P, the basal diet with an inclusion of ButiPEARL and PrimaLac at an inclusion
of 0.5 g/kg and 1.0 g/kg, respectively); and an antibiotic treated diet (A, the basal diet with an inclusion of 0.5 g/kg of bacitracin
methylene disalicylate).
2
Observed means were calculated from 16 replicate values using the pen as the experimental unit.
a-c
Means in a column not sharing a common superscript are different (P≤0.05).

1

0.089

0.513

B

8.156

0.513

8.164

BW
gain
(kg)

D 0 to 14

Growth performance data for individual feeder phases of experimental diets.1,2

C

Diets

Items

Feed
Intake
(kg)

Table 4.2

Table 4.3

Growth performance data for birds fed experimental diets from d 0-45 and
0-56.1,2

D 0 to 45
Feed
Intake
(kg)

BW
gain
(kg)

Feed
conversion
ratio

C

5.380

2.966c

B

5.377

B+P

D 0 to 56

Mortality

Feed
Intake
(kg)

BW
gain
(kg)

Feed
conversion
ratio

Mortality

1.837

5.556

8.499

4.275

2.065

6.250

3.058ab

1.799

2.222

8.424

4.249

2.037

2.593

5.357

3.002bc

1.813

2.431

8.413

4.180

2.064

3.125

P

5.394

3.093a

1.776

4.167

8.507

4.304

2.034

4.861

A

5.429

3.106a

1.787

2.778

8.538

4.343

2.031

3.820

SEM

0.045

0.032

0.016

1.195

0.077

0.047

0.017

1.302

P-value

0.843

0.009

0.069

0.253

0.741

0.165

0.374

0.299

Items
Diets

1

Experimental diets: control diet (negative control without any additives); a EBA
supplemented diet (B, the basal diet with an inclusion of 0.5 g/kg of ButiPEARL); a LAB
supplemented diet (P, the basal diet with an inclusion of 1.0 g/kg of PrimaLac); a diet
consisting of both EBA and LAB supplements (B+P, the basal diet with an inclusion of
ButiPEARL and PrimaLac at an inclusion of 0.5 g/kg and 1.0 g/kg, respectively); and an
antibiotic treated diet (A, the basal diet with an inclusion of 0.5 g/kg of bacitracin
methylene disalicylate).
2
Observed means were calculated from 16 replicate values using the pen as the
experimental unit.
a-c
Means in a column not sharing a common superscript are different (P≤0.05).
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Table 4.4

The effects of experimental diets1 on absolute weights (kg) of different
processing cuts on 57 d broilers.2

Live
Weight
(kg)

Carcass
Weight
(kg)

Abdominal
Fat Pad (kg)

Wings
(kg)

Breast
(kg)

Tenders
(kg)

C

4.487

3.411

0.057

0.346b

0.954

0.187

0.427

0.583

B

4.544

3.449

0.061

0.341b

0.947

0.190

0.430

0.587

B+P

4.528

3.464

0.057

0.354ab

1.034

0.190

0.431

0.597

P

4.589

3.518

0.055

0.367a

1.012

0.200

0.443

0.597

A

4.604

3.518

0.056

0.353ab

1.001

0.196

0.439

0.602

SEM

0.051

0.041

0.002

0.005

0.033

0.004

0.005

0.007

P-value

0.494

0.287

0.568

0.028

0.209

0.152

0.234

0.486

Items

Drumsticks
(kg)

Thighs
(kg)

Diets

1

Experimental diets: control diet (negative control without any additives); a EBA
supplemented diet (B, the basal diet with an inclusion of 0.5 g/kg of ButiPEARL); a LAB
supplemented diet (P, the basal diet with an inclusion of 1.0 g/kg of PrimaLac); a diet
consisting of both EBA and LAB supplements (B+P, the basal diet with an inclusion of
ButiPEARL and PrimaLac at an inclusion of 0.5 g/kg and 1.0 g/kg, respectively); and an
antibiotic treated diet (A, the basal diet with an inclusion of 0.5 g/kg of bacitracin
methylene disalicylate).
2
Observed means were calculated from 64 replicate values using the pen as the
experimental unit.
a-b
Means in a column not sharing a common superscript are different (P≤0.05).
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Table 4.5

The effects of experimental diets1 on relative to live weight (%) processing
characteristics on 57 d broilers.2

Dress
Weight
(%)

Abdominal
Fat Pad
(%)

Wings
(%)

Breast
(%)

Tenders
(%)

Drumsticks
(%)

Thighs
(%)

C

75.94

3.10

7.75abc

21.33

4.13

9.55

13.03

B

75.92

2.94

7.49c

20.71

4.14

9.56

13.02

B+P

76.48

2.78

7.86ab

22.73

4.16

9.51

13.17

P

76.57

2.76

7.97a

22.02

4.33

9.66

13.00

A

76.59

2.72

7.67bc

21.70

4.31

9.59

13.08

SEM

0.25

0.17

0.10

0.68

0.08

0.09

0.16

P-value

0.111

0.544

0.015

0.212

0.180

0.894

0.925

Items
Diets

1

Experimental diets: control diet (negative control without any additives); a EBA
supplemented diet (B, the basal diet with an inclusion of 0.5 g/kg of ButiPEARL); a LAB
supplemented diet (P, the basal diet with an inclusion of 1.0 g/kg of PrimaLac); a diet
consisting of both EBA and LAB supplements (B+P, the basal diet with an inclusion of
ButiPEARL and PrimaLac at an inclusion of 0.5 g/kg and 1.0 g/kg, respectively); and an
antibiotic treated diet (A, the basal diet with an inclusion of 0.5 g/kg of bacitracin
methylene disalicylate).
2
Observed means were calculated from 64 replicate values using the pen as the
experimental unit.
a-c
Means in a column not sharing a common superscript are different (P≤0.05).

80

Table 4.6

Items

The effects of experimental diets1 on relative weight to carcass weight (%)
processing characteristics on 57 d broilers.2

Abdominal
Fat Pad
Wings Breast Tenders Drumsticks Thighs
(%)
(%)
(%)
(%)
(%)
(%)

Diets
C

1.81

10.17

2.81

5.52

12.58

17.09

B

1.74

9.84

2.73

5.56

12.51

17.06

B+P

1.62

10.17

2.98

5.46

12.56

17.24

P

1.68

10.39

2.87

5.69

12.51

17.00

A

1.61

10.03

2.83

5.56

12.51

17.18

SEM

0.10

1.32

0.87

0.10

0.12

0.20

P-value

0.610

0.070

0.260

0.506

0.983

0.926

1

Experimental diets: control diet (negative control without any additives); a EBA
supplemented diet (B, the basal diet with an inclusion of 0.5 g/kg of ButiPEARL); a LAB
supplemented diet (P, the basal diet with an inclusion of 1.0 g/kg of PrimaLac); a diet
consisting of both EBA and LAB supplements (B+P, the basal diet with an inclusion of
ButiPEARL and PrimaLac at an inclusion of 0.5 g/kg and 1.0 g/kg, respectively); and an
antibiotic treated diet (A, the basal diet with an inclusion of 0.5 g/kg of bacitracin
methylene disalicylate).
2
Observed means were calculated from 64 replicate values using the pen as the
experimental unit.
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Figures

6

a

Mortality (%)

5
4
3

b
b

2

b

b

B

B+P
Treatment

1
0
C

P

A

1

Experimenal diets: a control diet (negative control without any additives) represented as
the grey solid bar; EBA supplemented diet (B, the basal diet with an inclusion of 0.5 g/kg
of ButiPEARL) represented as the bar containing solid diagonal lines; a diet consisting of
both EBA and LAB supplements (B+P, the basal diet with an inclusion of ButiPEARL
and PrimaLac at an inclusion of 0.5 g/kg and 1.0 g/kg, respectively) represented as the
bar containing divots; a LAB supplemented diet (P, the basal diet with an inclusion of 1.0
g/kg of PrimaLac) represented as the bar containing solid horizontal lines; and an
antibiotic treated diet (A, the basal diet with an inclusion of 0.5 g/kg of bacitracin
methylene disalicylate) represented as the black solid bar.
2
Observed means were calculated from 16 replicate values using the pen as the
experimental unit.
a-b
Means in a column not sharing a common superscript are different (P=0.01;
SEM=0.89; N=16).
Figure 4.1

Mortality experienced during feeder phase, d 28 – 45, of broilers fed
experimental diets.1,2
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CHAPTER V
EFFECTS OF AN ENCAPSULATED BUTYRIC ACID AND LACTIC ACID
PRODUCING BACTERIA USED ALONE OR IN COMBINATION
ON 57 D INTESTINAL MORPHOLOGY AND
IMMUNE TISSUES
Abstract
The dietary inclusion of both organic acids and lactic acid producing bacteria
(LAB) have been proposed as antibiotic alternatives in poultry diets. However, there is
limited research on the effects of combining LAB and organic acids. Thus, the objective
of this study was to determine if the dietary inclusion of organic acids, lactic acid
producing bacteria or the combination of these products from d 0-57, influenced the
broiler intestine or immune tissues. The 5 dietary treatments included; a basal diet (C),
C+an encapsulated butyric acid (B), C+LAB (P), C+both an encapsulated butyric acid
and LAB (B+P), and C+an antibiotic, BMD (A). On d0, 1,440 male Ross×Ross 708
chicks were placed into 80 floor pens. Birds were provided feed and water ad libitum.
Segments of the intestine were sampled at feed changes (1 bird per pen). Spleen and
bursa weights were collected on d14, 21, and 28. On d7 and 21 blood serum was
collected for α-1-acid glycoprotein levels. On d14, birds were challenged with a 10× dose
of a live coccidiosis vaccine. Data were analyzed using a randomized complete block
design and means were separated using Fisher’s protected LSD when P≤0.05. No
significant differences were observed for intestinal morphology (P>0.05). Birds fed B
and P, alone, demonstrated decreased relative duodenum length, while ileum length
increased over the 57d growout (P=0.037; P=0.040). In addition, birds fed P increased
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relative jejunum length (P=0.038). Birds fed diets with B+P resulted in increased relative
duodenum length, as well a decreased jejunum and ileum length (P=0.037; P=0.038;
P=0.040). Birds fed B and P, alone, demonstrated a reduced duodenum, jejunum, and
ileum pH overtime (P<0.0001; P=0.002; P=0.0004). Specifically, birds fed B+P
demonstrated elevated crop, jejunum, and ileum pH on d 45 compared to those fed C
(P<0.0001; P=0.005; P=0.002). On d 28, birds fed diets with B and B+P demonstrated
smaller relative spleens than those fed C or P (P=0.030). Birds fed diets containing B
reduced α-1-acid glycoprotein over time whereas, those fed P increased α-1-acid
glycoprotein (P<0.0001). In conclusion, separately, encapsulated butyric acid and LAB
were determined to improve intestinal and immune parameters, whereas, combining
encapsulated butyric acid and LAB did not improve any parameters.
Introduction
In 2006, the European Union finalized the ban on Antibiotic Growth Promoters
(AGPs) with the creation of Regulation 1831/2003, ultimately eliminating the use of all
AGPs (Castanon, 2007). In contrast, the United States poultry industry has begun
voluntarily phasing out AGPs, due to an increase in consumer concern over the
development of antibiotic resistance. The drastic reduction in the amount of antibiotics
utilized in animal feeds has resulted in a substantial increase of therapeutic antibiotics for
food animals (Castanon, 2007). As well, many integrators have experienced an increase
in “dysbacteriosis,” a condition in which the small intestine (SI) experiences an
overgrowth of bacteria. (Huyghebaert et al., 2010).
Dysbacteriosis could lead to an increase in infection and disease, such as necrotic
enteritis and coccidiosis. Necrotic enteritis occurs primarily in broilers of 2-6 wks of age,
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producing enteric lesions in the lower SI, jejunum and ileum; causing the intestines to
become distended and filled with dark brown fluid (Porter, 1998; Cooper and Songer,
2010). Further, necrotic enteritis typically occurs simultaneously with or as a secondary
infection from a coccidia infection, an enteric disease caused by Eimeria species (Shane
et al., 1985). The three most suitable species to induce Necrotic Enteritis in broilers are
E. maxima, E. acervulina, and E. necatrix (Williams, 2005). Annually, necrotic enteritis
and coccidiosis outbreaks are estimated to globally cost over $2 billion and $2.4 billion,
respectively (Van der Sluis, 2000).
With the United States’ poultry industry phasing out the use of AGPs, an
alternative with similar effects must be sought to maintain broiler performance, welfare,
and profit. AGPs have been shown to reduce the number of incidences and amplitude of
subclinical infections, as well as reduce the use of nutrients by bacteria. (Huyghebaert et
al., 2010). In addition, AGPs have been reported to improve absorption through the
thinning of the intestinal wall, and reduce the amount of ‘growth-depressing metabolites’
produced by Gram-positive bacteria. (Huyghebaert et al., 2010). Thus, an effective
alternative should possess many or most of the traits to improve weight gain, reduce
bacteria in the GIT, reduce nutrient competition, and reduce immune stimulation
(Economou and Gousia, 2015).
Many alternatives have been proposed to replace AGPs in the poultry industry
such as: exogenous enzymes, competitive exclusion products, prebiotics, probiotics,
herbs, etheric oils, acidic compounds, and bacteriophages (Huyghebaert et al., 2010; Van
Immerseel et al., 2009). Though all have different modes of action, the ultimate goal is
ameliorating the condition of the gastrointestinal tract by mitigating the presence of GIT
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enteric bacteria and improving the production of the bird (Van Immerseel et al., 2009).
Alternatives such as acidic compounds and lactic acid producing bacteria (LAB) work
similarly through their use of organic acids to improve the conditions of the
gastrointestinal tract (GIT) by reducing the colonization of pathogenic bacteria.
Acidic compounds are primarily composed of short chain fatty acids (SCFAs)
such as fumaric, propionic, acetic, lactic, butyric, and others. Organic acids (C1-C7,
SCFA) that are found to have a pKa, acid dissociation constant, between 3 and 5 are
used specifically for their antimicrobial activity (Papatisiros et al., 2013). There are two
major types of organic acids, those capable of lowering the pH of the stomach directly,
thus indirectly reducing bacteria, and those capable of lowering the pH of the GIT tract
by directly acting upon the cell wall of Gram-negative bacteria (Diener et al., 1993;
Papatisiros et al., 2013). Organic acids ameliorate the conditions of the GIT through the
reduction of GIT pH, promoting proteolytic enzyme activity and nutrient digestibility,
intensifying pancreatic secretions, encouraging digestive enzyme activity, creating
stability of the microbial population and stimulating the growth of beneficial bacteria,
and by being bacteriostatic and bactericidal to pathogenic bacteria (Papatisiros et al.,
2013). Also, certain organic acids, volatile SCFAs (VSCFA), possess the ability to target
the cell wall, cytoplasmic membrane, and specific metabolic functions in the cytoplasm
associated with replication, protein synthesis, and function (Ricke, 2003).
Although organic acids are the primary component for acidic compounds, specific
microorganisms such as LAB, produce organic acids. Probiotics such as LAB are capable
of protecting the GIT microflora through bacterial antagonism, bacterial interference,
barrier effect, competitive exclusion, and colonization resistance (Fuller, 1995). These
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actions are completed typically with the production of SCFAs, hydrogen peroxide, and
intermediary metabolites with antimicrobial activity (Huyghebaert et al., 2010). Certain
LAB, such as Lactobacillus spp. have the potential to decrease the external pH. Also, L.
acidophilus has the potential to lower pH to a greater extent than other LAB and can
reach a medium pH of 3.5 (Kashket, 1987). As well, the lactic acid produced by LAB
may be further utilized for the production of butyric acid by Clostridial clusters, crossfeeding (Tsai et al., 2005; Huyghebaert et al., 2010).
Although both organic acids and LAB have been proposed as alternatives to
AGPs, the benefits of their combination is unclear. Previous research has demonstrated
the detrimental effect organic acids have on lactic acid and LAB present in the GIT
(Thompson and Hinton, 1997; Impey and Mead, 1989; Hume et al., 1993). As early as
1989, research conducted by Impey and Mead (1989) concluded that the addition of 1.0
% of formic acid into a food slurry containing Salmonellas and Lactobacilli, resulted in
the death of all microorganisms. Also, it was seen by Hume et al. (1993) that organic
acids reduced LAB. Further, one study conducted by Thompson and Hinton (1997)
involving the use of Bio-Add (68% formic acid and 20% propionic acid) in a poultry diet,
resulted in an increase of propionic and formic acid, as well as a decrease in lactic acid
present in the crop (Thompson and Hinton, 1997). The interaction experienced by
Thompson and Hinton (1997) suggests that propionic and formic acid inhibit LAB.
Thus, the use of SCFA in poultry diets may be counterproductive to the overall
development of microflora in the GIT of broiler chickens.
Due to the potential of organic acids interacting detrimentally on the residential
LAB, further research needs to be conducted to explore the interaction between organic
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acids and LAB. As well, research needs to be further explored to investigate the potential
synergism that may exist between acidic compounds and LAB, as they both act upon the
GIT through the utilization of organic acids. Thus, it was the objective of the current
study to determine the effect of an encapsulated butyric acid (EBA), probiotic (LAB),
and their combination on gut morphology, physiology, pH, immune tissue weights, and
α-1-acid glycoprotein (α-1-AGP) levels in broilers when compared to a control and
industry standard.
Materials and Methods
Bird Husbandry
On day 0, 1440 day old male Ross × Ross 708 broiler chicks were obtained from
a commercial hatchery. Chicks utilized in this study were vaccinated for Marek’s disease,
Newcastle, and Gumboro disease. Upon farm arrival, chicks were grouped and placed in
respective floor pens according to d 0 body weight to reduce variation in mean body
weight. Eighteen birds were placed in pens and a total of 80 floor pens were used (5
treatments, 16 replicates). Placement stocking density on 0.062 sq. m./bird and increased
to 0.074 sq. m./bird by d 14. Floor pens in this study were comprised of a hanging
feeder, three nipple drinkers, and used broiler litter from a commercial broiler house.
Birds were supplied with water and feed ad libitum.
In the current trial, a photoperiod of 24 L:0 D from d 0 to 7 was utilized and
adjusted to a 20 L:4 D photoperiod from d 8 to 57. Upon placement (d0), lighting was
maintained at full intensity until d 10. On d 10, lighting was incrementally decreased to
2.5 lux candles until d 18 and maintained at 2.5 lux until the conclusion of the trial.
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House ambient temperature was 32.2°C at the onset of the trial and incrementally
decreased until 16.1°C was obtained on d 49.
Birds were raised according to the husbandry practices recommended by Aviagen.
All animals in this trial were treated in compliance with the Guide for the Care and Uses
of Agriculture Animals (Federation of Animal Science Societies, 2010).
Diet Preparation
All diets were formulated to meet or exceed the NRC and Aviagen guidelines
(NRC, 1994; Aviagen, 2014) for each dietary phase (Table 5.1). The four diet phases in
the current study were formulated utilizing a least cost-industry relevant diet consisting
primarily of corn, soybean meal, dried distiller’s grains, and poultry fat. Initially, a
common basal mash diet was batched, less the inclusion of dietary treatments, at the
Poultry Research Unit at Mississippi State University for the starter, grower, finisher I,
and finisher II diets. All basal diets were mixed dry for 5 min, and after the addition of
poultry fat, mixed for 10 min in a vertical screw mixer (907 kg capacity; Jacobson).
The inclusion of dietary treatments was made just prior to pelleting at the USDA
Poultry Research Unit in Starkville, Mississippi, a feed mill specialized in manufacturing
of experimental diets. The treatments were included in the diet according to the
manufacturer’s recommendations and sand was used as diluent to a total inclusion rate of
1.5 g/kg (Table 5.2). The five dietary treatments were as following: a basal diet
designated as the control (C), the basal diet with the inclusion of EBA (0.5 g/kg;
ButiPEARL, Kemin, Des Moines, Iowa) (B), the basal diet with the inclusion of LAB
(1.0 g/kg; PrimaLac, Star-Labs, Clarksdale, Montana) (P), the basal diet with the
inclusion of both EBA (0.5 g/kg) and LAB (1.0 g/kg) (B+P), and the basal diet with an
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antibiotic, bacitracin methylene disalicylate (0.5 g/kg; BMD-50, Alpharma, Fort Lee,
NJ.) (A). ButiPEARL™, an encapsulated butyric acid product is encapsulated using
MicroPEARLS spray freezing process, which enables the product to maintain a high
content of butyric acid (50%) and travel further down the GIT. PrimaLac® is a direct fed
microbial consisting of Lactobacillus acidophilus, Lactobacillus rhamnosus,
Bifidobacterium thermophilum, and Enterococcus faecium (PrimaLac, Star-Labs,
Clarksdale, Montana). Preliminary research indicated that 1 g of PrimaLac® contains
7.97 log CFU/mL of LAB after 8h of growth in vitro. For each treatment, dietary
additives (B, B+P, P, and A) were mixed with approximately 11 kg of basal diet for 5
min in a small horizontal mixer (11.34 kg capacity). Immediately following, diets were
mixed for 4 min in a horizontal ribbon mixer (907 kg capacity), prior to pelleting.
Regardless of phase, diets were pelleted using a 40 HP CPM with a 38.1 × 4.76
mm pellet die. The four dietary phases consisted of: a starter (d 0-14), grower (d 14-28),
finisher I (d 28-45), and finisher II (d 45-56). The starter was provided as crumbles.
Pellets were introduced at d 14 and fed for the remainder of the study.
Coccidia Challenge
On d 14, all birds were subjected to a coccidia challenge comprised of a 10 × dose
of a commercially available coccidiosis vaccine with live oocytes of the following
species of coccidia: Eimeria acervulina, Eimeria maxima, Eimeria maxima MFP,
Eimeria mivati, and Eimeria tenella (Coccivac®-B52, Intervet Inc.). The 10 × dose was
orally gavaged directly into the crops of 14 d old chicks regardless of treatment. Only
healthy birds were subjected to challenge. Lesion scores were not analyzed in the current
study.
94

Sample Collection
Samples were collected from one bird per pen on d 14, 21, 28, 45, and 56 for GIT
length, weights, and pH; spleen and bursa weights; GIT histology; and Chicken Alpha-1acid glycoprotein, (α-1-AGP). Birds were euthanized by means of cervical dislocation,
then the gizzard, duodenum, jejunum, and ileum were dissected and weighed.
Additionally, the duodenum, jejunum, and ileum were measured for length. The pH of
the contents of the crop, gizzard, duodenum, jejunum, and ileum were measured in situ.
As well, 2 cm section were taken at the midpoint of duodenum, point of entry of the bile
duct and Meckel’s diverticulum (jejunum), and midway between Meckel’s diverticulum
and ileocecal junction (ileum), flushed with a 1× phosphate buffered saline (PBS; Difco
BD™, Franklin Lanes, NJ), and set in 10 mL of 10% buffered formalin phosphate (Fisher
Scientific, Fair Lawn, NJ) for morphological analysis. On d 14 and 28, birds that were
euthanized for GIT sampling, were additionally sampled to obtain spleen and Bursa of
Fabricius weights. As well, on d 21, one bird per pen was euthanized solely for spleen
and bursa weight. On d 7 and 21, blood was drawn from the brachial vein of one bird per
pen to obtain α-1-AGP serum levels.
Gut Morphology
Although samples were collected for intestinal morphology for d 14, 28, 45, and
56, only d 45 samples were used for morphological examination. From the 2 cm intestinal
segments that were collected, samples were trimmed into < 4 mm pieces and transferred
into cassettes. Cassettes were stored in 10% formalin and sent to the Mississippi State
University College of Veterinary Medicine Diagnostic Laboratory for tissue processing.
Tissues were dehydrated, cleared, embedded in paraffin, and cut into 5 µm sections using
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a microtome. The 5 µm sections were mounted on glass slides and stained with Alcian
blue (ALB) stain to detect acid mucin-producing goblet cells (Lev and Spicer, 1964).
Villi, crypt, and muscle layers were examined under a light microscope (Laxco™
SeBa™ 3 Series Digital Microscope, Laxco, Inc., Bothell, WA) and photographed
according to the methods described by Fasina et al. (2010). ImageJ software (National
Institutes of Health, Bethesda, MD) was utilized to measure villus height (from tip to
bottom of each villus), mid- point villus width, crypt depth (from base to its opening),
and muscle thickness (from the submucosal and muscular layer boundary to the muscular
layer and peritoneum boundary. Further, morphometric parameters included calculated
villus area (villus height X mid-point villus width) and villus to crypt ratio (V:C; villus
height divided by crypt depth).
Gut Physiology
On d 14, 28, 45, and 57 the gizzard, duodenum, jejunum, and ileum were
dissected, measured for length, and weighed. Length was recorded and later adjusted to
account for the 2 cm sections that were removed for gut morphology. Weights were
recorded after digesta was removed from the gizzard, duodenum, jejunum, and ileum.
Individual lengths of the duodenum, jejunum, and ileum were analyzed relative to
the length of the entire SI. Individual weights of the duodenum, jejunum, ileum, and
overall weight of the SI were analyzed relative to respective sampling body weight. As
well, the individual weights of the duodenum, jejunum, ileum were analyzed relative to
overall SI weight.
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pH
The pH of the alimentary tract was measured according to the methods utilized by
Thompson and Hinton (Thompson and Hinton, 1997). An Accumet Excel XL60 probe
(Fisher Scientific) was utilized to measure the pH. The pH of the crop, gizzard,
duodenum, jejunum, and ileum were measured in situ by inserting the probe into an
incision made into the organ before the contents were removed. The pH for each sample
was measured within 30 minutes of birds being euthanized.
Immune Measurements
To evaluate the immune response of the birds fed EBA and LAB in the diet under
a challenge of coccidiosis, spleen and bursa weights were recorded on d 14, 21, and 28 in
accordance to the development of bursa of Fabricius (Glick, 1956). As well, blood
samples were collected from one bird per pen on d 7 and 21. Blood samples were
analyzed for α-1-AGP with an Enzyme-Linked Immunosorbent Assay kit (ELISA; Life
Diagnostics, West Chester, PA) and immediately analyzed under a microplate reader
(Synergy HT, Biotek, Winooski, VT) utilizing colorimetric detection at 450 nm. A
standard curve was obtained from the mean absorbance of standards and utilized to
determine the corresponding concentration of α-1-AGP in the plasma samples.
Statistical Analysis
Gut physiology, pH, and immune measurements were analyzed using a
randomized complete block design with a split plot over days. Morphological
measurements were analyzed utilizing a randomized complete block design with
subsampling. All data were analyzed by using PROC GLM of SAS 9.4 (SAS, 2014). The
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means were separated using Fisher’s protected LSD and were considered significant at P
≤ 0.05 (Steel and Torrie, 1980).
Results
Gastrointestinal Morphology
Due to the significant differences presented on d 45 in a companion study
(Chapter IV) and in the current study, d 45 was selected to observe morphological
differences. However, in the current trial, no significant differences were observed in the
villi height, villi width, crypt depth, mucosa thickness, villi area, or villi height to crypt
depth ratio in either the duodenum, jejunum, or ileum on d 45 (Table 5.3, P>0.05).
Numerical differences were observed with birds fed diets containing P having a greater
villus height in the duodenum and ileum, shorter crypt depth in the duodenum and
jejunum, thinner mucosa thickness, greater VH:CD in the duodenum, jejunum, and ileum,
and greater villus area than birds fed diets containing A. Numerically, birds fed diets with
B possessed shorter and narrower villi in the duodenum, jejunum, and ileum, shorter
crypt depth, thinner mucosa in the duodenum and jejunum, smaller villus area in the
duodenum and ileum, and greater villus area in the duodenum compared to birds fed with
A. Compared to birds fed with A, birds fed diets supplemented with B+P demonstrated
shorter villi in the duodenum and jejunum, narrower villi in the duodenum, jejunum, and
ileum, shorter crypt depth in the duodenum and jejunum, thinner mucosa in the
duodenum and jejunum, smaller villus area in the duodenum and ileum, and greater villus
area in the duodenum. However, numerical differences demonstrated in birds fed diets
with B+P were less than those observed in those fed diets containing B or P.
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Gastrointestinal Physiology and pH
For the convenience of the reader, the authors separated the results physiology
and pH into different segments of the GIT.
Crop. In the current study, there was a significant interaction for crop pH
between treatment and day (Figure 5.1A, P<0.0001). On d 14, the control birds
possessed a lower pH (4.46) compared to those fed diets containing B+P and P (5.01 and
5.03 respectively). As well, the pH of birds fed diets containing B, B+P, and P did not
differ from those fed diets with A on d 14 (4.89, 5.01, 5.03, and 4.56 respectively). Birds
of all dietary treatments were not different on d 28; however, on d 45, the birds fed C
demonstrated the lowest pH among birds fed dietary treatments (4.51). As well on d 45,
birds fed diets containing B+P obtained a higher pH (6.04) than those fed with C, B, or A
(4.51, 5.24, 5.41 respectively) and birds fed diets containing B+P did not differ from
those fed P (5.67). On d 56, no differences were observed between treatments. Over
time, only the C treated broilers experienced an increase in crop pH, 4.46 on d 14 to 5.00
on d 56. From d 14 to 28, pH decreased among all dietary treated broilers except those
fed C. Alternatively, pH from d 28 to 45 was increased among all dietary treatments, with
birds fed C showing no significant change. From d 45 to 56, the pH of birds fed C was
increased and the pH of those fed diets containing B+P, P, and A was decreased.
Gizzard. In the current study, a significant interaction between treatment and day
was observed for gizzard weight relative to BW (Figure 5.2A, P<0.0001). Birds fed diets
containing B demonstrated larger gizzard weight relative to BW (2.88), while birds fed
diets containing A possessed the lowest relative gizzard weight (2.42) than birds fed all
other dietary treatments on d 14. As time progressed, d 14 to 56, birds fed all dietary
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treatments experienced reduced gizzard weight relative to BW, 2.75 to 0.90 %. From d 45
to 56, birds fed all dietary treatments maintained relative gizzard weight, except those fed
diets containing B+P which decreased in size, 1.06 to 0.94 %.
A significant interaction on gizzard pH between treatment and day was also
observed in the current study (Figure 5.2B, P=0.002). On d 14, pH was higher in the
gizzards of birds fed diets containing B+P, P, and A (3.03, 2.94, 2.70 respectively), than
in those fed diets with C or B (2.46 and 2.52). On d 28, no differences in gizzard pH were
demonstrated among birds fed all dietary treatments; on d 45, the gizzard pH was
significantly lower in birds fed diets containing B and B+P (2.72 and 2.70), compared to
those fed with C and A (3.21 and 3.26). On d 56, no differences were observed between
birds fed dietary treatments. From d 14 to 28, only the gizzard pH of birds fed diets
containing B+P was reduced from 3.03 to 2.47. Birds fed diets with C and A
demonstrated increased gizzard pH from d 28 to 45 (2.81 and 2.64 to 3.21 and 3.26
respectively). Whereas, no significant differences were observed from d 28 to 45 among
birds of all dietary treatments. From d 45 to 56, birds fed with C and A did not experience
change in pH. However, broilers fed diets with the addition of B, B+P, and P did
demonstrate increase gizzard pH from d 45 to 56 (2.72, 2.70, 2.93 to 3.29, 3.31, 3.36
respectively).
Duodenum. A significant treatment by day interaction was observed for
duodenum length relative to SI length (Figure 5.3A, P=0.037). On d 14, birds fed diets
with A possessed longer duodenum lengths relative to SI length, 20.52%, compared to
birds fed diets containing C and B+P, 18.77 and 19.07% respectively. As well, on d 14,
birds fed diets containing B were not significantly different from those fed with A (20.23
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and 20.52% respectively) and had a higher percent of relative length than those fed with
C (18.77%). Although no differences were observed on d 28, on d 45, birds fed diets
containing B+P presented the greatest relative length (SI), 21.78%. On d 56, broilers fed
diets containing B and P demonstrated shorter relative duodenum lengths than those fed
with C, 17.39, 17.98 and 19.04 % respectively. Over time, birds fed diets containing C
demonstrated no significant change in relative duodenum length, whereas the duodenum
of birds fed diets with B, P, and A were shorter on d 56 (18%) than on d 14 (20%).
Relative duodenum length of B+P treated broilers was increased from d 14 to 45 (19 to
22%) and decreased from d 45 to 56 (22 to 19 %).
In the current study, there was a significant treatment by day interaction in the
duodenum weights relative to BW (Figure 5.3B, P<0.0002). On d 14, both birds fed diets
containing C and B demonstrated higher relative duodenum weight (BW) than birds fed
all other dietary treatments (0.87, 0.93, 0.75, 0.76, and 0.79 respectively). However, on d
28, 45, and 56, no differences were observed between birds fed different dietary
treatments. Over time, the relative duodenum weight (BW) of all birds, regardless of
treatment, decreased (0.08 to 0.03%). Although there was a decrease in relative
duodenum weight (BW) from d 14 to 56, birds fed diets containing B+P, P, and A were
constant from d 14 to 28 and d 45 to 56.
There was a significant interaction between treatment and day in the duodenum
weight relative to SI weight of broilers fed experimental diets (Figure 5.3C, P=0.026).
On d 14, birds fed diets containing B+P and P possessed lighter relative duodenums (SI)
(19%) than those fed with C, B, or A (21%). On d 28, birds fed with B+P obtained
greater relative duodenum weights (SI) than those fed with B. However, no treated
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broilers demonstrated differences among relative duodenum weight (SI) on d 45 and 56.
From d 14 to 56, birds fed diets containing B experienced a decrease in relative
duodenum weight (SI) (21.99 to 19.43%), whereas those fed with B+P obtained an
increase in relative duodenum weight (SI) (19.25 to 21.13 %). From d 14 to 28, relative
duodenum weight (SI) of birds fed diets with B+P and P increased; however, from d 28
to 45, birds fed with B+P and P demonstrated a decrease in relative duodenum weight
(SI) (19, 22, and 20 % on d 14, 28, and 45 respectively).
A significant treatment by day interaction was observed for duodenum pH
(Figure 5.3D, P=0.0004). On d 14, birds fed diets with C possessed lower pH in the
duodenum than birds fed all other treatments (6 compared to 6.5). On d 14, 28, or 56 no
differences were observed between birds fed dietary treatments. However, on d 45, birds
fed diets containing B+P obtained a higher pH in the duodenum compared to those fed B
(6.24 compared to 6.02), but birds fed B+P were not different than those fed P or A diets.
Over time, birds, regardless of experimental diet, demonstrated a decrease in duodenum
pH (6.5 to 6.0); whereas, birds fed the control did not significantly change. Birds of all
dietary treatments demonstrated a decrease in duodenum pH from d 14 to 28. From d 28
to 45 and 45 to 56, birds fed diets containing C, B, P, and A experienced no change in
duodenum pH. However, birds fed diets with B+P experienced an increase (5.94 to 6.24)
in duodenum pH from d 28 to 45, and a decrease (6.24 to 5.91) from d 45 to 56.
Jejunum. Jejunum length relative to total SI length was significantly affected by
dietary treatments (Figure 5.4A, P=0.038). Birds fed the control, C, and dietary P
demonstrated increased relative jejunum length compared those fed with B+P and A, 40

102

% compared to 39.5%. Birds fed diets containing B did not alter relative jejunum length
compared those fed all other dietary treatments.
Dietary treatments significantly affected jejunum weight relative to the SI (Figure
5.4B, P=0.027). The A treated broilers (43%) possessed lower relative jejunum weight
(SI) compared to C, B, and P treated broilers (45 %). Birds fed diets containing B+P were
not significantly different than those fed with A.
In the current study, a significant treatment by day interaction was observed for
the jejunum pH of dietary treatments (Figure 5.4C, P=0.005). On d 14, both birds fed
with diets containing B+P and presented higher pH in the jejunum compared to those fed
with C, B, and A (6.4 compared to 6). On d 28 and 56, no differences were observed
between birds fed dietary treatments, however, on d 45, birds fed with B demonstrated
lower pH in the jejunum compared to birds fed diets supplemented with C, B+P, P and A
(5.5 compared to 6.0 respectively). As well, on d 45, broilers fed diets containing B+P
(6.15) had higher jejunum pH than those fed C or B diets (5.84 and 5.47). From d 14 to
56, the jejunum pH f was decreased from >6.0 to ≈5.7 in birds fed diets containing B,
B+P, and P dietary supplements. Only birds fed diets containing B+P and P demonstrated
lower pH from d 14 to 28 (6.4 to 5.9). Whereas, the jejunum pH of B treated broilers
were no different from d 14 to 28, but decreased from d 28 to d 45 (5.81 to 5.47).
Ileum. There was a significant interaction in ileum length relative to total SI
length between treatment and day in the current study (Figure 5.5A, P=0.040). On d 14,
birds fed diets containing B demonstrated smaller relative ileum length (SI) compared to
birds fed all other treatments (37 % compared to 40 %). On d 28, 45, and 56 no
differences were observed between birds fed different dietary treatments. Over time,
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relative ileum length of birds fed diets containing B, P and A were increased (40% to
43%). Birds fed diets with B experienced a 3% increase in ileum relative length from d
14 to 28, no significant change from d 28 to 45, and a 3% increase from d 45 to 56.
Unlike birds fed diets containing B, broilers fed diets with P and A experienced no
change in ileum relative length from d 14 to 45 and a 3 % increase from 45 to 56. Birds
fed diets with B+P experienced no change in relative ileum length from d 14 to 28 and d
28 to 45, however, from d 14 to 45 birds fed diets containing B+P demonstrated a
decrease in relative ileum length (SI) around (2%) and an increase (3 %). from d 45 to 56.
There was a significant treatment by day interaction observed in ileum weight
relative to total SI (Figure 5.5B, P=0.007). On d 14, birds fed diets containing B+P
demonstrated greater relative weight (SI) compared to those fed with C, B, and P (36%
compared to 33%). On d 28, birds fed diets containing B+P possessed lower relative
ileum weight (SI) than those fed diets with A (31 % compared to 33 %). No differences
between birds fed different dietary treatments were observed on d 45, with birds from all
treatments having around a 36 -37 % relative ileum weight (SI). From d 14 to 56, birds
fed diets containing B, P, and A experienced an increase in relative ileum weight (34 to
38%). An increase relative ileum weights (SI) was also observed from d 14 to 56 in birds
fed diets with C (33 to 35%). Both birds fed diets containing B+P and P experienced a
decrease in relative ileum weight (SI) from d 14 to 28 (6 and 2 % reduction respectively).
However, birds from all dietary treatments demonstrated an increase in relative ileum
weight (SI) from d 28 to d 45 (4-6 % reduction). As well, birds fed diets containing A
experienced a 2% increase in relative ileum weight (SI) from d 45 to 56, whereas a 3%
decrease was reported in those fed C treated diets from d 45 to 56.
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A significant treatment by day interaction was observed in ileum pH (Figure 5.4
C, P=0.002). On d 14, birds fed the control treatment, C, obtained a lower pH than all
other dietary treatments (5.6 compared to >6.0). On d 28, the ileum pH of birds fed diets
containing B+P was higher than those fed C or B (5.95 compared to 5.41 and 5.48
respectively). Similarly, birds fed diets containing B+P possessed higher ileum pH than
birds fed C on d 45 (6.5 compared to 6.0). On d 56, birds fed diets with B and P,
separately, resulted in lower ileum pH than those fed C (5.7 compared to 6.4), but those
fed B and A were not different than those fed A. From d 14 to 56, the ileum pH of birds
fed C increased (5.6 to 6.3), whereas, the ileum pH of birds fed diets containing B and P,
separately, decreased (6.3 to 5.7). Both birds fed diets containing B and P experienced a
decrease in ileum pH from d 14 to 28 (6.23 and 6.30 5.48 and 5.71 respectively). Birds
fed diets containing B and B+P experienced an increase in ileum pH on d 28 to 45 and a
decrease from d 45 to 56.
Immunology
By altering the GIT, the largest immune organ in the body, the immune related
parameters may be enhanced or hindered (Kraehenbuhl and Neutra, 1992). Both immune
associated organs and α-1-AGP levels in blood serum were measured in the current trial.
Treatment by day interactions were observed in the current study for both spleen relative
weight and α-1-AGP serum levels (P=0.030 and P<0.0001). However, relative bursa
weights were not affected by dietary treatments (P=0.077).
Spleen weights were significantly affected by a treatment by day interaction in the
current study (Figure 5.6A, P=0.030). On d 14, before administration of the challenge,
birds of all dietary treatments possessed similar spleen weights relative to BW. On d 21,
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7 days after the administration of the coccidia challenge, birds fed diets containing B+P
developed higher relative spleen weight compared to those fed P (0.13 and 0.11 %
respectively). And on d 28, both birds fed diets containing B and B+P experienced
significantly lower relative spleen weight when compared to those fed the control, C, or P
(0.11 and 0.11 % compared to 0.13 and 0.14 % respectively).
There was a significant interaction in α-1-AGP serum between treatment and day
(Figure 5.6B, P<0.0001). In the current study, on d 7 (prior to the coccidia challenge),
birds fed diets containing B+P, P, and A presented lower α-1-AGP levels compared to
birds fed diets containing C or B. As well, on d 7, birds fed diets with B+P, P, and A
were statistically different from one another with birds fed B+P presenting the lowest α1-AGP levels at 0.41 mg/mL. However, on d 21, birds fed diets supplemented with A
possessed the lowest α-1-AGP levels (α-1-AGP levels were too low to detect, represented
as 0.00 mg/mL). Further, birds fed diets containing B demonstrated the second lowest α1-AGP levels at 0.39 mg/mL. Also on d 21, birds fed diets with P obtained the highest
levels (1.22 mg/mL). Overall, from d 7 to 21, birds fed diets with C, B, and A
demonstrated decreased α-1-AGP levels; whereas those fed B+P, and P experienced
increased α-1-AGP serum levels.
Discussion
Pressure to remove antibiotics from poultry diets has increased the need for an
effective antibiotic alternative capable of maintaining broiler performance and health.
AGPs have been shown to enhance broiler performance by reducing bacterial
proliferation, thinning of the GIT, and stimulating the gut-associated lymphoid tissues
(GALT) (Coates et al., 1955; Coates et al., 1963; Visek, 1978a; Anderson et al.,1999;
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Frankel et al., 1994; Kraehenbuhl and Neutra, 1992). The supplementation of LAB and
organic acids individually have demonstrated their effectiveness as antibiotic alternatives,
capable of improving broiler performance, reducing pathogenic bacteria and protecting
against coccidiosis. (Gunal et al. 2006; Vlademirova and Sourdjiyska, 1996; Jin et al.,
1998; Vogt et al., 1981; Runho et al., 1997; Shobha & Ravindranath, 1991; Garcia et al.,
2007; Abbas et al., 2011; Dalloul et al., 2005). However, little is known about the effects
of their combination. Thus, the antibiotic alternative treatments, organic acids, LAB, and
their combination, were evaluated on their efficacy on improving morphology of the SI,
size and pH of the GIT, weight of organs associated with immune response, and α-1-acid
glycoprotein serum levels under challenged conditions, compared to an industry standard
and untreated diet.
It has been reported that both EBA (Kaczmarek et al., 2016) and LAB (Rahimi et
al., 2009) are able to affect the morphology of the SI. Although there were no significant
differences in the current study, numerical differences existed. Previously, EBA has been
reported to increase villi length and decrease crypt depth in the ileum compared to a
control (Kaczmarek et al., 2016). Whereas, the current study demonstrated a numerical
decrease in villi length and greater crypt depth in the ileum of birds treated with EBA
compared to those fed the control or BMD. In contrast, broilers fed diets containing LAB
numerically increased villi length and decreased crypt depth in the duodenum and ileum.
This is in agreement with Salim et al. (2013) and Cao et al. (2013) who fed different LAB
species, Lactobacillus reuteri and Enteroccoccus facium, to poultry and reported
improvements in morphology such as an increased ileum villus height, mucosa thickness,
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and decreased crypt depth. These enhancements observed in LAB treated broilers may
lead to greater nutrient absorption and less cell turnover (Choct, 2009).
Although numerical differences existed, SI morphology was not significantly
affected by treatments (Table 5.2, P>0.05). In agreeance with the current study, Wang et
al. (2016) observed no morphometrical differences between a control, prebiotic, Bacillus
based probiotic, anticoccidial, and antibiotic treated broiler diets in broilers challenged
with a live coccidia (P>0.05). Also, Waguespack Levy et al. (2015) recorded the addition
of EBA to broiler diets to have no impact on duodenum and ileum morphology when
compared to a control (P>0.05). Research has also demonstrated the supplementation of
LAB (PrimaLac) in poultry diets to have no effect on SI villi or crypts (Rahimi et al.,
2009). Further, the villus height and mucosal thickness of the jejunum and ileum of
broilers fed a combination of organic acid (Genex) and LAB probiotic (Protexin) dietary
supplement have demonstrated no difference than those fed diets containing an antibiotic
or the control diet (P<0.05; Gunal et al., 2006).
Despite mixed reports on the effect organic acid and LAB have on the SI
morphology, it has been shown that an increase in villi height may be associated with an
increase in SI absorption (Awad et al., 2011). However, in the current trial no
morphometrical parameters were significant. Thus, overall physiological changes may be
more indicative of SI function such as nutrient absorption and utilization.
EBA was the only dietary supplement to increase gizzard weight in the current
study. Whereas, birds fed BMD demonstrated decreased relative gizzard weight
compared to all other treatments. In previous research, coated sodium butyrate at varying
levels had no effect on gizzard size of broilers when compared to a control (Dolan et al,
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2016). As well, a LAB probiotic (PrimaLac) has been shown to have no effect on gizzard
weight when included in poultry diets when compared to control or salinomycin treated
diets (Chichlowski et al., 2007). It has been hypothesized that a heavier gizzard may
indicate a better ability to break down and digest dietary nutrients, such as starch (Svihus,
2011a); however, as broilers are fed pelleted macronutrients, gizzard structure would not
be expected to differentiate between birds fed the same pelleted basal diet. Thus, EBA
may not have benefitted gizzard function on d 14.
The SI is the primary site for digestion and nutrient absorption, thus the SI plays a
vital role in poultry performance and health (Svihus, 2014). The SI begins at the
duodenum which makes a loop, the duodenal loop, around the pancreas starting at the
gizzard (Sturkie, 1999). The duodenum continues to digest nutrients, due to overflow of
bile salts from the gizzard (Svihus, 2014). In the current study, birds fed diets containing
EBA, LAB and BMD, provided separately, comparatively decreased relative duodenum
length. In agreement with the current study, Miles et al. (2006) concluded that birds fed
BMD supplemented diets reduced duodenum length. The inclusion of BMD has also
been shown to decrease SI size, while improving nutrient utilization (Dibner and
Richards, 2005). Although, birds fed diets containing EBA and LAB provided separately,
were comparative to those fed BMD, birds fed the combination of EBA and LAB
demonstrated increased relative duodenum length (SI) over time. A longer duodenum
may be indicative of a greater retention time and result in an increase in fat absorption, as
95 % of fat is absorbed in the duodenum (Sklan et al., 1975). However, in a companion
study, the combination of EBA and LAB did not improve growth performance (Chapter
IV).
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As well as altering duodenal length, birds fed diets containing EBA and LAB
experienced decreased relative duodenum weight (SI and BW). However, on d 14, birds
fed diets containing LAB had higher relative duodenum weight (BW) than those fed the
combination, LAB, or BMD. Ideally, a lighter duodenum weight is preferred as a smaller
relative SI size (BW) may be indicative of the allocation of energy for growth
performance over maintenance (Wang et al., 2016).
The jejunum is the primary section of the SI responsible for nutrient absorption
(Svihus, 2014). By the end of the jejunum, a large majority of major nutrients such as fat
(Noy and Sklan, 1995; Sklan et al., 1975; Hurwitz et al., 1973), starch (Riesenfield et al.,
1980), and protein (Noy and Sklan, 1995; Sklan and Hurwitz, 1980) are absorbed. Thus,
altering the jejunum should be a primary goal of dietary alternatives to promote increased
nutrient digestibility.
In the current study, birds fed diets supplemented with LAB demonstrated
increased relative jejunum length and weight (SI) compared to those fed the antibiotic,
BMD. LAB (PrimaLac) has previously been shown to promote no differences in jejunum
length when compared to the negative control and antibiotic, enramycin, when fed to
broilers during a Clostridial challenge on d 16 (Abudabos, 2012). However, the increase
in size, especially length, may be beneficial for nutrient utilization as it may serve to
decrease the feed passage rate, increasing the nutrient absorption that takes place there
(Svihus, 2014). The increase of the jejunum could also be indicative of more fermentative
bacteria residing within (Dibner and Richards, 2005). However, due to the fermentative
nature of LAB (Kandler, 1983), LAB have the potential to increase the size of the
jejunum. This is contrary to the mechanism of antibiotics, which inhibit the growth of
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fermentative bacteria and thus have been recorded reducing the length and size of the
GIT (Miles et al., 2006; Dibner and Richards, 2005).
As previously discussed, birds fed diets supplemented with BMD have
demonstrated a decrease jejunum size (Miles et al., 2006). In the current study, birds fed
diets containing EBA resulted in greater jejunum weight than those fed BMD, however,
the length of the jejunum of EBA treated diets were comparative to those supplemented
with BMD. A similar length, but greater relative weight may indicate that birds fed EBA
possessed a thicker mucosa. A thinner mucosa has been linked with enhanced nutrient
absorption, which is seen with the supplementation of BMD (Dibner and Richards, 2005;
Miles et al., 2006). However, in the companion study, birds fed diets containing EBA
demonstrated similar broiler performance compared to those fed the control and
antibiotic (Chapter IV).
At the conclusion of the jejunum, the ileum begins, only separated by the
Meckel’s Diverticulum (Sturkie, 1999). The ileum is the primary site of water and
mineral absorption in the SI; however, it has been reported that some nutrient digestion
may also occur (Svihus, 2014). To an extent, nutrients such as starch and fat may be
absorbed in the ileum (Zimonja and Svihus. 2009; Hurwitz et al, 1973). The addition of
BMD into broiler diets has resulted in the decrease of SI size (Miles et al. (2006),
however, in the current trial, birds fed diets containing BMD resulted in a significant
increase in relative length and weight (SI) over time. In addition to birds fed BMD
increasing relative ileum length and weight (SI) over time, both birds fed diets containing
EBA and LAB, separately, were capable of increasing relative ileum length and weight
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(SI), while those fed the combination of EBA and LAB had no significant effect on
length over time.
An increased ileum length could result in an increased area for nutrient
absorption. The dietary inclusion of LAB (PrimaLac) have been recorded to increase
relative ileum length during a Clostridial challenge compared to a positive control on d
16 (Abudabos, 2012); whereas, EBA (ButiPEARL) has been shown to increase overall SI
length (Mahdavi and Torki, 2009). Wang et al. experienced no morphological
improvements when utilizing a probiotic, Bacillus subtilus, but hypothesized that an
increase in SI length may result in greater cumulative growth. However, as previously
mentioned little nutrient absorption occurs in the ileum and thus the increase in relative
length may indicate energy being allocated to maintenance rather than growth of the
broiler.
Altering the pH of the GIT is another reported function of the dietary
supplementation of organic acids and LAB (Papatisiros et al., 2013; Huyghebaert et al.,
2010). In the current study, feeding birds diets containing EBA and LAB resulted in no
change in crop pH. Not only did birds in the current study possess crop pH higher than
4.51, the average pH of the crop recorded in literature (Sturkie, 1999), an increase in pH
was observed from d 14 to 45. Typically, over time, the pH of GIT should remain
relatively consistent (Herpol, 1966).
The supplementation of EBA in poultry diets may have been ineffective in
reducing crop pH due to its encapsulation, as it typically does not dissociate until it
reaches the lower GIT (Ruhnke et al., 2014). As well, LAB feed supplements (PrimaLac)
have been shown to increase the presence of Lactobacillus in the crop (Falaki, et al.,
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2011); however, the lactic acid produced may not have been sufficient enough to
decrease crop pH. As both EBA and LAB supplemented diets presented little effect on
the pH over time, it is unclear why the combination of EBA and LAB resulted in such
inconsistent pH from d 14, 28, 45, and 56.
As was seen in the crop, birds fed diets containing EBA and LAB, provided
separately, experienced an increase in gizzard pH overtime, with birds fed the
combination of EBA and LAB not differing from d 14 to 56. However, diets
supplemented with EBA and the combination of EBA and LAB showed the potential to
reduce gizzard pH compared to the control on d 45, possibly improving performance on d
45. A more acidic pH may indicate a potential improvement in nutrient utilization and gut
health (Svihus, 2011a). In a companion study, broilers fed diets containing EBA had
similar BWG from d 0-45 than birds fed the control (Chapter IV). Although an increase
in pH among birds fed diets containing EBA, LAB, and their combination was
experienced from d 45 to 56, the pH of all treatments was below 3.5, the average pH
recorded by Svihus (2011a). Previous research on the addition of formic, fumaric, acetic,
and citric acid separately added in poultry diets resulted in the reduction of gizzard pH to
obtain a pH around 3.30 on d 42 (Ghazalah et al., 2011). Although in the current study,
an overall reduction was not seen, on d 56, pH of all segments was still in range with
those found by Ghazalah et al. (2011).
Previous research has demonstrated the ability of organic acids and LAB feed
supplements to reduce extracellular pH (Ghazalah et al., 2011; Murry et al., 2004),
however, in the current study, all birds, regardless of experimental diet, displayed
elevated duodenum pH on d 14 compared to the control, however, no differences were
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observed between birds fed experimental diets and control on d 28, 45, and 56. Although
birds fed diets containing the antibiotic and antibiotic alternatives possessed higher pH on
d 14 than the control, all dietary treatments were capable of lowering the duodenum pH
over time, while the control maintained pH. The consistent pH of birds fed the control is
consistent with the hypothesis that age has no effect on pH (Herpol, 1966). Whereas, the
decrease in pH of dietary treatments over time, demonstrates their ability to lower GIT
pH (Ghazalah et al., 2011; Murry et al., 2004).
As seen in the duodenum, EBA, LAB, and their combination were capable
lowering jejunum pH over time. As the jejunum is the main site for nutrient absorption,
the jejunum pH is expected to be more neutral than the crop, gizzard, and duodenum and
be above 6 (Svihus, 2011). However, the nutrient absorption in the SI has been recorded
to be enhanced by a more acidic pH, below 6 (Rahmini et al., 2014). Although LAB
produce lactic acid which has the potential to decrease extracellular pH (Huyghebaert et
al., 2010), birds fed LAB in the current study did not possess lower jejunum pH lower
than those fed the control. However, as seen on d 45, birds fed EBA presented lower
jejunum pH than all other treatments. The decrease in jejunum pH of EBA treated
broilers is in agreement with the understanding that encapsulated butyric acid is released
into the lower GIT (Ruhnke et al.,2014).
Similar to the jejunum, pH of the ileum is typically above 6 due to the role of
digestive enzymes in the jejunum and ileum (Svihus, 2011b). Sturkie (1999) has recorded
the pH of the ileum to range from 6.3 to 6.4, whereas, Herpol and van Grembergen
(1967) have record pH to be around 7.2. As organic acids have demonstrated capabilities
of reducing pH as far as the ileum (Ghazalah et al., 2011), it is unclear why the dietary
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supplementation of EBA had no effect on the ileum pH in the current study. As well,
oral administered strains of LAB have been shown to have no significant effect on ileum
pH compared to a control (Olnood et al., 2015).
As stated previously, pH should not increase due to bird age (Herpol, 1966),
however, the use of both EBA and LAB utilize SCFAs to lower extracellular pH
(Papatisiros et al., 2013; Huyghebaert et al., 2010). Thus, the overtime decrease in ileum
pH presented by broilers fed diets containing EBA and LAB, separately, may benefit
pathogen reduction and nutrient utilization (Fernández-Rubio et al., 2009; Abudabos,
2012).
In the crop, duodenum, jejunum, and ileum, pH was elevated on d 45 in birds fed
the combination of EBA and LAB. The increase in pH of birds treated with the
combination may be attributed to the effect EBA may elicit on the LAB (introduced
through the utilization of PrimaLac). Thompson and Hinton (1997) experienced a
decrease in lactic acid in the crop after the administration of formic and propionic acid
(Bio-Add) and concluded that organic acids may decrease residential LAB. As the EBA
is encapsulated and not limited to the crop (Ruhnke et al., 2014), this may have allowed
LAB to be affected not only in the crop, but in the SI. This may further indicate the
ineffectiveness of the combination on improving broiler performance and health.
By altering the GIT, the largest immune organ in the body, the immune related
parameters may be enhanced or hindered (Kraehenbuhl and Neutra, 1992). Both immune
associated organs and α-1-AGP levels in blood serum were measured in the current trial.
Previous research has demonstrated that a larger spleen weight may be indicative of a
stronger immune response (Møller et al., 1998a, 1998b, 2003). In the current study, birds
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fed diets containing LAB experienced similar relative spleen weights compared to birds
fed the control. The current study is in agreement with Kabir et al. (2004) who
demonstrated the use of probiotics containing LAB, such as Protexin, are capable of
increasing spleen weight in both vaccinated and non-vaccinated broilers. As well, organic
acids, such as formic, fumaric, citric, and acetic, have been shown to increase spleen,
bursa, and thymus relative weights (Ghazalah et al., 2011). However, in the current trial,
both EBA and the combination of EBA and LAB fed broilers possessed similar relative
spleen weights on d 14 and 21 and lower relative spleen weight on d 28 compared to
those fed the control. Thus, based on the decrease of size of relative spleen weight, EBA
and the combination of EBA and LAB may present a lower immune response.
Although spleen weight has been linked to a stronger immune system (Møller et
al., 1998a, 1998b, 2003), spleen weight has also been shown to vary due to stress,
parasite load, ontogeny, gender, and migration events (Smith and Hunt, 2004). Further,
splenomegaly occurs in the presence of an infection, in direct contrast with previous
findings (Brown and Brown, 2002). Due to these factors, conclusions concerning immune
function cannot be based solely on spleen weight.
However, α-1-AGP serum levels were also investigated in the current study.
Presence of α-1-AGP has been associated with the acute phase response which is
activated by IL-1, IL-6, and TNF α (Fournier et al., 2000). Thus, an increase of α-1-AGP
may indicate an elevated immune response due to an illness. Eckersall (2000) elaborated
that an elevated AGP may indicate more chronic issues, as was seen in cows. In the
current study, 7 d prior to the coccidia infection, birds fed diets containing the
combination of EBA and LAB, LAB, and BMD all presented lower α-1-AGP levels on d
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7 when compared to those fed diets containing EBA and the control. If only looking prior
to the challenge, the combination of EBA and LAB, LAB, and BMD may have prevented
the need for a greater acute phase response. However, 7 d after the coccidia challenge
(one life cycle of oocysts), birds supplemented with diets containing BMD experienced a
reduction of α-1-AGP to untraceable levels. BMD has been established as an effective
dietary supplement to protect poultry from infection (Dibner and Richards, 2005).
Further, birds fed diets containing EBA also experienced a decrease in α-1-AGP levels
over time; which is in agreeance with Zhang et al. (2011). Birds fed diets containing
LAB however, experienced an increase in α-1-AGP levels over time. Unlike AGPs and
EBA, probiotics have demonstrated the ability to stimulate several different categories of
cells associated with the immune system (Maassen et al., 2000; Christensen et al., 2002;
Dallout et al., 2003; Bal et al., 2004). Thus, LAB may have stimulated a greater response
of α-1-AGP than other treatments. Birds fed diets containing the combination of EBA
and LAB also experienced an increase α-1-AGP levels over time and the increase could
be due to the nature of the supplemented LAB compared to EBA alone. However, the
combination still provided a lower α-1-AGP serum level than EBA fed alone.
Conclusion
In conclusion, the supplementation of EBA or LAB alone in diets may improve
broiler gut function comparative to AGPs. In the current study, nutrient absorptive area
was enhanced in both EBA and LAB diets, as both were capable of decreasing the length
of the duodenum, increasing the length of the ileum, and decreasing SI pH over a 57 d
growout. LAB may be more effective as an antibiotic alternative than EBA, as birds fed
LAB were capable of increasing the length of the jejunum in addition to the ileum. This
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is in agreement with the companion study, where birds fed diets supplemented with LAB
demonstrated performance similar to those fed BMD (Chapter IV). As well, the
supplementation of EBA and LAB may provide protection during an infection or disease
outbreak. Birds fed diets containing EBA and LAB demonstrated a decrease in GIT pH
over time, potentially providing a hurdle for pathogens to colonize the GIT. As well, both
altered the immune response variables in response to a coccidia challenge. This is in
agreeance with the companion study where mortality was alleviated in birds fed dietary
treatments when compared to those fed the control (Chapter IV). The results of the
current trial conclude that the combination of EBA and LAB may not be beneficial to
overall gut physiology as it did not provide any improvements to the GIT and decreased
jejunum length thus reducing the overall area for nutrient absorption. These conclusions
are in agreeance with the companion study (Chapter IV). However, further studies are
necessary to determine the impact the combination of EBA and LAB provided in broiler
diets has on the SI microflora of broilers.
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Tables
Table 5.1

Composition of feed ingredients and calculated nutrient contents of basal
diets

Item
D 0 to 14
D 14 to 28
D 28 to 45
D 45 to 56
Ingredient1, %
Corn
58.453
63.660
72.944
76.681
Soybean Meal
32.464
23.628
17.636
16.369
cDDGS
3.000
5.000
2.1637
0.000
ProPlus 552
3.000
4.000
4.000
3.886
Poultry Fat
0.500
1.039
0.598
0.525
Defluorinated Phosphate
1.026
0.725
0.583
0.506
Calcium Carbonate
0.137
0.561
0.590
0.556
L-Lysine hydrochloride
0.233
0.344
0.332
0.316
DL-Methionine
0.304
0.293
0.252
0.235
Vitamin-Trace Min PM Nutrablend 30003
0.273
0.273
0.273
0.273
Sodium Bicarbonate
0.095
0.130
0.197
0.216
L-Threonine
0.084
0.091
0.085
0.080
Salt, NaCl
0.219
0.047
0.135
0.146
Quantum Blue4
0.030
0.030
0.030
0.030
Selenium Premix
0.022
0.022
0.022
0.022
HostazymX5
0.010
0.010
0.010
0.010
Sand/Treatment6
0.150
0.150
0.150
0.150
Nutrient Contents7
ME (Kcal/kg)
2,996
3,073
3,124
3,148
CP, %
22.805
20.255
17.357
16.381
Crude fiber, %
2.752
2.807
2.491
2.602
Crude fat, %
3.443
4.751
4.388
4.254
Ca, %
0.671
0.780
0.730
0.680
Available P, %
0.335
0.330
0.300
0.280
Na, %
0.196
0.136
0.176
0.176
Digestible lysine, %
1.200
1.100
0.940
0.890
Digestible methionine, %
0.601
0.559
0.488
0.460
Digestible TSAA, %
0.912
0.836
0.733
0.694
Digestible threonine, %
0.780
0.726
0.6298
0.596
1
Ingredient nutrient composition were analyzed before formulating the diet.
2
H.J. Baker’s ProPlus 55 Animal Protein Concentrate
3
Premix provided the following per kilogram of finished diet: manganese, 0.02 mg; zinc, 0.02 mg; iron,
0.01 mg; copper, 0.0025 mg; iodine, 0.0003 mg; selenium, 0.00003mg; folic acid, 0.69 mg; choline, 386
mg; riboflavin, 6.61 mg; biotin, 0.03 mg; vitamin B6, 1.38 mg; niacin, 27.56 mg; pantothenic acid, 6.61
mg; thiamine, 2.20 mg; menadione, 0.83 mg; vitamin B12, 0.01 mg; vitamin E, 16.53 IU; vitamin D3,
2,133 ICU; vitamin A, 7,716 IU (NB3000, Nutrablend, Neosho, MO).
4
Quantum Blue provided the following per kilogram of finished diet: not less than 10,000,000 FTU of
Phytase (Quantum Blue, AB Vista, Marlborough, Wiltshire).
5
Hostazym X provided the following per kilogram of finished diet: Endo-1,4-beta-xylanase, 15,000,000
EPU.
6
Experimental Additives [ButiPEARL (0.5 g/kg of finished feed), PrimaLac (1.0 g/kg of finished feed),
combination of ButiPEARL and PrimaLac (0.5 g/kg and 1.0 g/kg of finished feed, respectively), and
bacitracin methylene disalicylate (0.5 g/kg of finished feed)] were added in replacement of sand.
7
Nutrient contents were calculated on a dry matter basis.
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Table 5.2

Villi height, villi width, crypt depth, mucosa thickness, villus area, and
villus height to crypt depth ratio in 45 d old broiler chickens.
C

B

B+P

P

A

P-value

SEM

Height (µm)

1808.89

1479.28

1439.39

1706.39

1675.39

0.397

105.91

Width (µm)

276.50

210.78

206.44

211.67

274.56

0.334

22.35

Crypt Depth (µm)

294.11

249.50

251.94

226.17

305.89

0.284

13.24

Mucosa Thickness (µm)

190.22

209.11

219.17

223.72

233.17

0.599

18.57

Villus Area (mm)

0.514

0.331

0.320

0.366

0.461

0.280

0.056

VH:CD

6.397

6.314

5.81

7.75

5.669

0.273

0.487

Height (µm)

1421.67

1087.22

1151.78

1006.11

1231.22

0.240

117.41

Width (µm)

252.56

239.72

213.17

217.94

215.17

0.232

21.46

Crypt Depth (µm)

201.72

185.22

181.56

146.44

193.33

0.602

16.17

Mucosa Thickness (µm)

206.22

165.72

204.72

175.44

208.78

0.261

16.21

Villus Area3 (mm)

0.355

0.278

0.267

0.239

0.265

0.219

0.034

VH:CD

7.879

6.227

6.604

7.19

6.415

0.442

0.775

Height (µm)

780.72

635.44

873.56

918.39

813.00

0.212

89.55

Width (µm)

197.22

176.11

169.22

211.00

189.78

0.436

27.01

Crypt Depth (µm)

107.00

131.44

146.56

147.33

133.56

0.172

14.44

Mucosa Thickness (µm)

205.17

177.94

249.94

176.61

169.00

0.156

20.31

Villus Area3 (mm)

0.153

0.116

0.152

0.208

0.169

0.293

0.032

VH:CD

7.411

5.416

6.275

6.839

6.266

0.228

0.448

Duodenum
3

Jejunum

Ileum

C, control diet; B, EBA; B+P, EBA + LAB; P, LAB; A, BMD; and VH:CD, villus height
to crypt depth ratio.
No differences were observed (P>0.05).
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A. The pH of the crop of broiler chickens fed experimental diets: a control diet (negative
control without any additives) represented as the grey solid bar; an EBA supplemented
diet (B, the basal diet with an inclusion of 0.5 g/kg of ButiPEARL) represented as the bar
containing solid diagonal lines; a diet consisting of both EBA and LAB supplements
(B+P, the basal diet with an inclusion of ButiPEARL and PrimaLac at an inclusion of 0.5
g/kg and 1.0 g/kg, respectively) represented as the bar containing divots; a LAB
supplemented diet (P, the basal diet with an inclusion of 1.0 g/kg of PrimaLac)
represented as the bar containing solid horizontal lines; and an antibiotic treated diet (A,
the basal diet with an inclusion of 0.5 g/kg of bacitracin methylene disalicylate)
represented as the black solid bar.
a-f
Means in a column not sharing a common superscript are different (P<0.0001, N=16,
SEM=0.173).
Figure 5.1

(A) Effects of dietary treatments on the crop during a 57 d growout.
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A. Gizzard weight relative to body weight of broiler chickens fed experimental diets: a
control diet (negative control without any additives) represented as the grey solid bar; an
EBA supplemented diet (B, the basal diet with an inclusion of 0.5 g/kg of ButiPEARL)
represented as the bar containing solid diagonal lines; a diet consisting of both EBA and
LAB supplements (B+P, the basal diet with an inclusion of ButiPEARL and PrimaLac at
an inclusion of 0.5 g/kg and 1.0 g/kg, respectively) represented as the bar containing
divots; a LAB supplemented diet (P, the basal diet with an inclusion of 1.0 g/kg of
PrimaLac) represented as the bar containing solid horizontal lines; and an antibiotic
treated diet (A, the basal diet with an inclusion of 0.5 g/kg of bacitracin methylene
disalicylate) represented as the black solid bar.
a-h
Means in a column not sharing a common superscript are different (P<0.0001, N=16,
SEM=0.042).

122

4
abc

3.5

abcd bcde
def

3
f

def def

abc

ab ab a a abc

cde
def def

ef ef
f

f

pH

2.5
2
1.5
1
0.5
0
14

28

45

56

Day
C

B

B+P

P

A

B. Gizzard pH of broiler chickens fed experimental diets: a control diet (negative control
without any additives) represented as the grey solid bar; an EBA supplemented diet (B,
the basal diet with an inclusion of 0.5 g/kg of ButiPEARL) represented as the bar
containing solid diagonal lines; a diet consisting of both EBA and LAB supplements
(B+P, the basal diet with an inclusion of ButiPEARL and PrimaLac at an inclusion of 0.5
g/kg and 1.0 g/kg, respectively) represented as the bar containing divots; a LAB
supplemented diet (P, the basal diet with an inclusion of 1.0 g/kg of PrimaLac)
represented as the bar containing solid horizontal lines; and an antibiotic treated diet (A,
the basal diet with an inclusion of 0.5 g/kg of bacitracin methylene disalicylate)
represented as the black solid bar.
a-f
Means in a column not sharing a common superscript are different (P=0.002, N=16,
SEM=0.128).
Figure 5.2

(A-B) The effect of dietary treatments on the weight and pH of the gizzard
in broiler chickens throughout a 57 d growout.
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A. Duodenum length relative to small intestine length of broiler chickens fed
experimental diets: a control diet (negative control without any additives) represented as
the grey solid bar; an EBA supplemented diet (B, the basal diet with an inclusion of 0.5
g/kg of ButiPEARL) represented as the bar containing solid diagonal lines; a diet
consisting of both EBA and LAB supplements (B+P, the basal diet with an inclusion of
ButiPEARL and PrimaLac at an inclusion of 0.5 g/kg and 1.0 g/kg, respectively)
represented as the bar containing divots; a LAB supplemented diet (P, the basal diet with
an inclusion of 1.0 g/kg of PrimaLac) represented as the bar containing solid horizontal
lines; and an antibiotic treated diet (A, the basal diet with an inclusion of 0.5 g/kg of
bacitracin methylene disalicylate) represented as the black solid bar.
a-f
Means in a column not sharing a common superscript are different (P=0.037, N=16,
SEM=0.519).
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B. Duodenum weight relative to body weight of broiler chickens fed experimental diets:
a control diet (negative control without any additives) represented as the grey solid bar;
an EBA supplemented diet (B, the basal diet with an inclusion of 0.5 g/kg of
ButiPEARL) represented as the bar containing solid diagonal lines; a diet consisting of
both EBA and LAB supplements (B+P, the basal diet with an inclusion of ButiPEARL
and PrimaLac at an inclusion of 0.5 g/kg and 1.0 g/kg, respectively) represented as the
bar containing divots; a LAB supplemented diet (P, the basal diet with an inclusion of 1.0
g/kg of PrimaLac) represented as the bar containing solid horizontal lines; and an
antibiotic treated diet (A, the basal diet with an inclusion of 0.5 g/kg of bacitracin
methylene disalicylate) represented as the black solid bar.
a-e
Means in a column not sharing a common superscript are different (P≤0.0002, N=16,
SEM=0.023).
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C. Duodenum weight relative to small intestine weight of broiler chickens fed
experimental diets: a control diet (negative control without any additives) represented as
the grey solid bar; an EBA supplemented diet (B, the basal diet with an inclusion of 0.5
g/kg of ButiPEARL) represented as the bar containing solid diagonal lines; a diet
consisting of both EBA and LAB supplements (B+P, the basal diet with an inclusion of
ButiPEARL and PrimaLac at an inclusion of 0.5 g/kg and 1.0 g/kg, respectively)
represented as the bar containing divots; a LAB supplemented diet (P, the basal diet with
an inclusion of 1.0 g/kg of PrimaLac) represented as the bar containing solid horizontal
lines; and an antibiotic treated diet (A, the basal diet with an inclusion of 0.5 g/kg of
bacitracin methylene disalicylate) represented as the black solid bar.
a-h
Means in a column not sharing a common superscript are different (P=0.026, N=16,
SEM=0.622).
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SEM=0.074).
Figure 5.3

(A-D) The effect of dietary treatments on the length, weight, and pH of the
duodenum of chickens during a 57 d growout.
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a-b
Means in a column not sharing a common superscript are different (P=0.038, N=64,
SEM=0.314).
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Means in a column not sharing a common superscript are different (P=0.027, N=64,
SEM=0.374).
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Figure 5.4

(A-C) The effect of dietary treatments on the length, weight, and pH of the
jejunum of broilers during a 57 d growout.
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Means in a column not sharing a common superscript are different (P=0.040, N=16,
SEM=0.750).
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Figure 5.5

(A-C) The effect of dietary treatments on the length, weight, and pH of the
ileum of broiler chickens during a 57 d growout.
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SEM=0.006).
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Figure 5.6

(A-B) The effects of dietary treatments on immune parameters (spleen
weight and α-1-acid glycoprotein) in broiler chickens during a 57 d
growout.
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CHAPTER VI
CONCLUSION
Antibiotic growth promoters (AGPs) have been a vital tool of the poultry industry
to improve broiler performance and welfare. However, consumer demand and recent
legislation have led antibiotic withdrawal in many countries. With the loss of AGPs, the
poultry industry has increased efforts in identifying an effective antibiotic alternative. An
effective alternative would improve overall broiler performance by demonstrating a
beneficial effect on pathogen presence, gut physiology and morphology, as well as the
immune response. Both LAB and organic acids have demonstrated beneficial effects on
these parameters, however there is limited literature concerning their combination in
broiler diets.
Research from this thesis (Chapter III), dietary feed supplements, EBA and
LAB, were evaluated for their ability to reduce Salmonella Heidelberg, in vitro. Both
EBA and LAB demonstrated the potential to decreases nalidixic resistant Salmonella
Heidelberg, in vitro, however, both were more effective at a lower initial S. Heidelberg
concentration. As well, it was established that EBA may be capable of providing greater
protection to poultry than LAB from pathogens, as EBA sustained S. Heidelberg
reduction throughout the entirety of the trial. Further, both products have the potential to
reduce pathogenic bacteria in vitro, however, further studies need to be conducted to
identify the products efficacy on pathogenic reduction in vivo.
The supplementation of EBA, LAB, and their combination on broiler performance
and welfare was investigated in the current thesis (Chapter IV). Results of a 57 d
growout and processing demonstrated the efficacy of LAB supplemented in poultry diets
143

as an alternative to AGPs, as birds fed diets containing LAB performed comparatively to
those fed BMD. As well, the dietary inclusion of EBA in poultry diets was concluded to
enhance broiler performance similar to the dietary addition of AGPs, however birds fed
diets supplemented with LAB outperformed those fed diets with EBA. It was concluded
that the combination of EBA and LAB may not be beneficial to performance of broilers,
as birds fed diets containing the combination demonstrated no improvement in
performance characteristics. However, further studies were conducted to understand the
impact the combination of EBA and LAB had on the GIT of broilers in comparison to
EBA and LAB alone.
In the current thesis, the effect of the supplementation of EBA, LAB, and their
combination in broiler diets on GIT morphology, physiology, and pH, and immune
parameters were also investigated (Chapter V). It was demonstrated that birds fed diets
containing both EBA and LAB, when supplemented alone, experienced improved broiler
gut function compared to those fed diets containing AGPs. Nutrient absorptive area was
enhanced in birds fed diets with EBA and LAB, separately, which may lead to greater
performance of broilers. As well, in the current study, it was demonstrated that
supplemented LAB may be more effective as an antibiotic alternative than EBA. Further,
the dietary supplementation of EBA and LAB may provide protection during an infection
or disease outbreak, as birds fed diets containing EBA and LAB experienced a decrease
in GIT pH over time and altered immune response variables in response to a coccidia
challenge. The results of the current thesis conclude that the dietary supplementation of
the combination of EBA and LAB may not be beneficial to overall gut physiology, which
is in agreement with the findings reported in broiler performance (Chapter IV).
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However, further studies are necessary to determine the impact the combination of EBA
and LAB provided in broiler diets has on the SI microflora of broilers.
In conclusion, both EBA and LAB, when supplemented into broiler diets
separately, are capable of improving the performance of broilers during a coccidia
infection. Birds fed diets containing EBA and LAB may have demonstrated improved
performance from the altered physiology and pH of the SI and immune response. Further,
LAB was determined to be a more effective dietary alternative to AGPs than EBA or the
combination. Lastly, the combination of EBA and LAB did not appear to be an effective
dietary alternative to AGPs. It is recommended that further research investigates the
effect EBA, LAB, and the combination of EBA and LAB have on the microbiome of the
SI. The shift in SI microflora could exploit certain beneficial properties of these
supplements. Lastly, the combination of different LAB and organic acids at varying
concentrations should be explored to determine if a possible synergism is plausible.
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